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This study examines changes in cytoplasmic ribosomes that 
accompany drug resistance in MCF-7 breast cancer cells.  Differences in 
ribosomal protein composition between drug susceptible and drug resistant 
cell lines were examined.  Ribosomes were isolated from mitoxantrone 
susceptible and mitoxantrone resistant MCF-7 cells. The acid extracted 
ribosomal proteins were subjected to optimized 2DGE using a “zoom” strip (pI 
7-11) for the first dimension separation.  Further optimization of 2DGE 
included the use of a 15mM DTT wick at the cathode end of the focusing tray, 
decreasing the protein loading amount and using large format gels for the 
second dimension.  Forty-nine ribosomal proteins were identified in the drug 
susceptible cell line.  Two novel protein isoforms of the proteins RPS3 and 
one novel isoform of RPS10 were identified in the drug resistant cell line.   
 Methods for the extraction and detection of ribosomal proteins from the 
2D gel were developed.  The method of Mirza et.al. was modified and used to 
 
 
extract ribosomal proteins from the gel.  The detection of these proteins was 
optimized by the use of 50% ACN/1.0% TFA to solubilize the MALDI matrix.  
In addition, the extracted protein solution was mixed 1:1 with 5% Triton X-
100.  Intact molecular weights were determined for 41 ribosomal proteins 
using high performance MALDI-TOF mass spectrometry. 
 The average number of ribosomes per cell was determined for the 





































MASS SPECTROMETRIC ANALYSIS OF CYTOPLASMIC  
RIBOSOMAL PROTEINS IN DRUG RESISTANT  













Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Professor Catherine Fenselau, Chair 
Professor Jonathan Dinman 
Professor Peter Gutierrez 
Professor Douglas Julin 

























© Copyright by 


























My time and effort in graduate school as well as this thesis is dedicated to my 
son, Noah Hays.  He inspires me to not allow anything to stand in the way of 




I would first like to acknowledge my friends and family for their support.  
I must start with Noah, who never lets me think about work too much when 
I’m not there.  My mother, Barabara Hays, provides guidance and is always 
willing to help.  Natasha Smith shows me what friendship means.  Rachael 
Strong is always willing to listen.  Sunny Wang inspires me to be strong. 
Cheryl Lane makes me laugh so hard.  Barabara and Warren Freeman are 
my biggest cheerleaders.  Suzanne Kilgore gives pure love and support.   
The people of the lab, past and present, have provided the best 
working atmosphere and make me want to come to work on lazy days, 
sometimes. My co-workers, Jeff Whiteaker, Steve Swatkoski, Andrei Chertov 
and Scott Russell were always willing to provide perspective, and I thank 
them.  
I would like to thank Dr. Catherine Fenselau for her commitment to see 
me through.   
 
 iv
Table of Contents 
 
Dedication ....................................................................................................... ii 
Acknowledgements ........................................................................................ iii 
Table of Contents ........................................................................................... iv 
List of Tables .................................................................................................. vi 
List of Figures................................................................................................ vii 
Chapter 1: Introduction ....................................................................................1 
Ribosomes...................................................................................................1 
Ribosome Structure..................................................................................3 
Ribosome Function ..................................................................................6 
The Reported Changes of Ribosomes and Ribosomal Proteins ..............9 
Proteomics .................................................................................................11 
Two Dimensional Gel Electrophoresis .......................................................13 
Mass Spectrometry ....................................................................................16 
Post-Translational Modifications ................................................................19 
Bottom-Up Approach ..............................................................................21 
Top-Down Approach ..............................................................................22 
Protein Identification and Bioinformatics ....................................................25 
Hypothesis and Objectives.........................................................................27 




Cell Culture and Harvest ........................................................................29 
Isolation of Ribosomes and Extraction of Ribosomal Proteins ...............30 
Two-Dimensional Gel Electrophoresis ...................................................32 
Image Analysis and Comparative Densitometry.....................................36 
In-Gel Digestion and Desalting ...............................................................36 
Mass Spectrometry ................................................................................38 
Protein Identification ...............................................................................39 
Isolation of Protein Isoforms and Mass Measurement............................42 
Absolute Quantitation .............................................................................44 
Error Analysis .........................................................................................45 
Chapter 3: Results.........................................................................................47 
Reproducible Method for Isolation and Purification of Ribosomal Proteins 47 
Optimization of 2DGE and Protein Identification ........................................47 
Comparative Study between Parental and MitoxantroneR MCF-7 Cells ....63 
Characterization of Protein Isoforms..........................................................69 
Absolute Quantitation of Ribosomes..........................................................74 
Chapter 4:  Discussion ..................................................................................79 
Characterization of the Ribosome..............................................................79 
Bottom-Up Characterization of the Ribosome............................................80 
Optimization of 2D Gel Analysis .............................................................80 




Top-Down Characterization of the MCF-7 Ribosome ................................89 
Optimization of Extraction of Ribosomal Proteins from Gels......................91 
MALDI Optimization for Molecular Mass Determination.............................93 
Intact Molecular Weights............................................................................93 













































Table 3.1: Proteins identified using the bottom-up approach from 2D gels………………..54-55 
Table 3.2: Sequence coverage of proteins using the bottom-up approach………………..56-62 
Table 3.3: Relative quantitation of proteins with altered abundances…………………………66 
Table 3.4: Result of precision study of the MALDI-TOF………………………………………...70 
Table 3.5: Intact molecular weights of the ribosomal proteins………………………………….73 
Table 4.1 The list of human ribosomal proteins in the SwissProt database……………….84-85 




































Figure 1.1 Three step process of protein synthesis……………………………………………...8 
Figure 1.2 Scheme for identification of proteins using a bottom-up approach……………….15 
Figure 1.3 Ion path in the quadrupole time-of-flight mass spectrometer……………………..18 
Figure 1.4 Schematic representation of matrix-assisted laser desorption ionization………..20 
Figure 1.5 Dominant fragmentation pattern of a peptide……………………………………….23 
Figure 2.1 Scheme of 2DGE………………………………………………………………………34 
Figure 2.2 Comparison of 2D gels from using the Compugen Z3 program…………………..35 
Figure 2.3 Protein identification using peptide mass fingerprinting……………………………40 
Figure 2.4 Protein identification using Tandem MS……………………………………………..41 
Figure 2.5 Intact molecular weight determination……………………………………………….43 
Figure 3.1 Evaluation of method 1 for isolation of ribosomal proteins………………………..48 
Figure 3.2 Evaluation of method 2 for isolation of ribosomal proteins………………………..49 
Figure 3.3 Evaluation of method 3 for isolation of ribosomal proteins………………………..50 
Figure 3.4 Comparison of 2D gel of ribosomal proteins before and after optimization……..52 
Figure 3.5 Annotated gel of ribosomal proteins…………………………………………………53 
Figure 3.6 Zoomed views of the 2D gels of ribosomal proteins……………………………….64  
Figure 3.7 Compugen image of the comparison of the parental cell line and the mitoxantrone 
resistant cell line…………………………………………………………………………………….65 
Figure 3.8 RPS3 protein abundance changes…………………………………………………..67 
Figure 3.9 RPS10 protein abundance changes…………………………………………………68 
Figure 3.10 The intact molecular weight of the standard apomyoglobin……………………..70 
Figure 3.11 Overlay of the spectra from the precision study…………………………………..72 
Figure 3.12 Bar graph representation of the number of cell per harvest……………………..76 
Figure 3.13 Bar graph representation of the number of ribosome per harvest………………77 
Figure 3.14 Bar graph representation of the number of ribosomes per cell………………….78 













Chapter 1: Introduction 
Ribosomes 
Ribosomes synthesize all cellular proteins, making their role in cell 
growth and proliferation absolutely critical for survival.  The ribosome is made 
up of ribosomal RNA (rRNA) and proteins. Initially the proteins were believed 
to be the catalysts in the polymerization of amino acids to form polypeptides, 
but it was discovered that the rRNA was functioning as the enzyme [1, 2].  In 
order for the ribosome to synthesize a protein, it requires: a template which 
dictates the sequence of amino acids, the amino acids themselves, and the 
energy to form the new peptide bonds.   
The template from which the ribosome synthesizes the protein is in the 
form of messenger RNA (mRNA).  Messenger RNA is a complementary 
transcript of the gene in the DNA blueprint.   Messenger RNA contains 
codons, which are base pair triplets that code for a certain amino acid.   In 
eukaryotic cells, the DNA and the ribosomes are spatially segregated.  The 
mRNA serves to deliver the sequence information by traveling from the 
nucleus to the ribosome in the cytoplasm.  In many cases the mRNA 
molecule is altered or modified during this transition.   
In order to synthesize the protein using amino acid building blocks, a 
supply of activated amino acids is necessary.  Ribosomes incorporate amino 
acids, which are activated by attachment to transfer RNA (tRNA) and ATP.  
The tRNA carries the amino acid to the ribosome and the GTP provides the 
energy to form the new peptide bond.  The tRNA contains an anticodon, 
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which is complementary to the codon.  This anticodon interacts with the 
codons on the mRNA molecule to ensure the correct amino acid is added to 
the polypeptide chain.  Once the proofreading function is carried out, the 
amino acid is incorporated into the growing polypeptide chain.   
Ribosomes are so abundant in actively growing cells, they can account 
for up to 30% of the dry weight of the cell. The specific amount of ribosomes 
in a cell depends on the activity of the cell or the tissue to which the cell 
belongs.  With the exception of cells that have a secretory function, most 
ribosomes are found free in the cytoplasm of the cell.   
Ribosomes are assembled in the nucleolus of the cell.  Pre-rRNA is 
transcribed in the nucleus and extensively modified to yield the mature rRNA 
species in the nucleolus.  Modification of the pre-rRNA in eukaryotes includes 
methylation of the sugar 2’ hydroxyl group or pseudouridine formation.  The 
ribosomal proteins, which are synthesized by cytoplasmic ribosomes, are 
transported to the nucleolus.  The proteins associate with the maturing rRNA 
segments as they are being processed from the pre-rRNA.   The current 
belief is that the individual pre-ribosomal subunits are transported out of the 
nucleus through the nuclear pore complex [3].  Further processing occurs in 
the cytoplasm which results in the mature ribosomal subunits.  
Although ribosomal function has been conserved across nature, 
structural differences occur between prokaryotes and eukaryotes.  For 
prokaryotic ribosomes, the RNA to protein ratio is about 2:1 by weight, the 
molecular mass is about 2.5 x 106 Da, and the diameter is about 200-250 Å.  
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Conversely, eukaryotic ribosomes have an RNA to protein ratio of about 1:1 
by weight, the molecular mass is about 4 x 106 Da, and the diameter is about 
250-300 Å [3, 4].  While chloroplasts and mitochondria are found in 
eukaryotes, their ribosomes do not resemble the 80S eukaryotic ribosomes.   
Chloroplast ribosomes strongly resemble the 70S ribosomes of eubacteria 
and blue-green algae.  The characteristics of mitochondrial ribosomes 
depend on the organism from which they are derived, and are therefore more 
diverse.  
 
 Ribosome Structure 
The ribosome is made up of two subunits, termed the large subunit 
and the small subunit.  The intact ribosome, as well as each subunit, is 
characterized in terms of their sedimentation coefficient.  For eukaryotes, the 
sedimentation coefficients are 80S for the intact ribosome and 60S and 40S 
for the large and small subunits respectively.  For prokaryotes, the intact 
ribosome has a sedimentation coefficient of 70S while the large and small 
subunits have values of 50S and 30S respectively.  The subunits are found 
separated in the cell unless actively translating an mRNA transcript.  
Extensive electron microscopy studies as well as cross-linking studies have 
been performed in order to determine the shape of the individual subunits as 
well as the intact ribosome [5, 6].  X-ray crystallography studies have also 
been performed, initially only on ribosomal subunits but eventually on intact 
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ribosomes from bacteria, to obtain a more detailed understanding of the 
interaction between the rRNA and ribosomal proteins.   
The most recent crystal structure reported for a ribosome was 
published in Science in 2005 and was for the intact 70S ribosome of the E. 
coli at 3.5Å resolution [7].  Previously, structures were reported for the 70S 
ribosome for T. thermophilus at 5.5Å [8] in addition to two versions of the 
crystal structure of T. thermophilus small ribosomal subunit, one which was 
obtained at 3.0Å resolution[9], the other at 3.3 Å [10].  A 3.1Å resolution 
structure for the large subunit from D. radiodurans was reported in 2001 [11] 
and a 2.4Å resolution structure was reported for the large subunit of H. 
marismortui in 2000 [12].  Although ribosomes have remained fairly 
conserved evolutionarily, differences exist.  The number of proteins observed 
in the ribosome and the length of the various rRNA molecules vary from 
species to species [4].  Ribosomes from multiple sources must be studied in 
order to understand the structural and functional effects of these changes in 
rRNA and proteins.    
The rRNA determines the overall shape of the ribosomal subunits.  
The rRNA is also characterized by its sedimentation coefficient.  Since the 
first work was done on E. coli ribosomes, the sedimentation coefficients 
assigned to the rRNA species are only accurate for E. coli.  The small subunit 
contains one rRNA molecule which is 16S in E. coli or 16S-like in other 
organisms.  The 16S-like rRNA in human cytoplasmic ribosomes is 1880 
nucleotides long.  The large subunits of bacteria consist of a 23S rRNA.  The 
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large subunit of eukaryotes contains two, strongly interacting rRNA species: 
the 23S-like and the 5.8S.  The 23S-like rRNA contains about 5,025 
nucleotides in the human cytoplasmic ribosome, while the 5.8S contains 
about 160.  In all prokaryotes and eukaryotes, the large subunit also contains 
a 5S rRNA, which is about 120 nucleotides long.   
The eukaryotic ribosome contains about 75-80 proteins [13].  Most of 
the proteins are extremely basic with a pI range of about 9-13.  There are a 
few exceptions with pI values about 6 [4].  The molecular weights of the 
majority proteins are in the range of 10kDa to 30kDa.  Two eukaryotic 
ribosomal proteins have molecular weights in the range of 50-60kDa, while 
there are 10 small proteins which have molecular weights under 10kDa.  The 
small subunit of the eukaryotic ribosome contains about 30 proteins, while the 
large subunit contains about 50.  The E. coli ribosome contains 55 total 
proteins, which helps explain the difference in the rRNA to protein ratio in 
prokaryotes versus eukaryotes.  Almost all of the proteins are present in a 
single copy per ribosome.  The E. coli ribosomal proteins were named based 
on a gel electrophoresis experiment performed in 1970 by Kaltschmidt and 
Wittman [14].  The subunits were separated and a 2D electrophoresis 
experiment was performed.  The proteins were numbered starting from one at 
the top of the gel and counting down to the bottom.  Similar experiments were 
run for different species and therefore ribosomal proteins across the species 
had their own nomenclatures according to the electrophoretic map.  For this 
reason, the protein number corresponding to a protein in E. coli has no 
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association with a protein of the same number in humans.  When it was 
discovered that ribosomal proteins were relatively conserved, homologies 
were determined, and family groups were assigned.  Thirty-one proteins of 
the E. coli ribosome share sequence homology with eukaryotic proteins [15].  
In order to gain understanding of how a given protein interacts with the rRNA, 




Protein synthesis occurs in three distinct steps: initiation, elongation 
and termination, which are illustrated in Figure 1.1.  Initiation is the stage in 
which the ribosomal subunits come together with an mRNA molecule, the 
initiator tRNA, and some elongation factors.  Elongation occurs as the mRNA 
transcript is “read” and amino acids are added to the initiating amino acid to 
form the polypeptide chain.  Termination involves the end of the elongation 
process and dissociation of the translational components.   
Each step contains multiple interactions allowing the ribosome to 
continue incorporating amino acids.  The initiator complex is formed as the 
40S subunit binds to an mRNA molecule as can be seen in panel A of Figure 
1.1.  The initiator tRNA, which contains a methionine residue, is activated by 
binding to a molecule of ATP.  An important characteristic of the initiator tRNA 
is that it has preferable affinity for the P (peptidyl tRNA) site and it is not 
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recognized by elongation factor 1, which is usually involved in bringing 
aminoacyl-tRNA’s to the ribosome.  
Initiation factors are bound to the ribosome in a complex with GTP and 
subsequently released by GTP hydrolysis.  For example, initiation factor 2(IF-
2) assembles with the ribosome as a complex of aminoacyl-tRNA and GTP 
and catalyzes the binding of aminoacyl-tRNA to the P site in the ribosome.   
The initiator complex is bound to the start codon on the mRNA molecule.  
Initiation factor-3 prevents association of the large subunit with the small 
subunit until all of the other factors are in place.  The 60S subunit binds to the 
complex, and the initiation factor is released from the complex.  The rate 
limiting step of initiation is the binding of an mRNA to the 40S subunit 
because of the selection of the mRNA molecule as well as the correct 
positioning of the start codon.  The ribosome is ready to accept a tRNA 
molecule into the A (aminoacyl tRNA) site and begin the elongation process.   
Elongation consists of a series of steps which are repeated until the 
stop codon of the mRNA has been reached.  Panel B of Figure 1.1 illustrates 
the sequence.  In the first step, the tRNA carrying an amino acid is bound to 
the A site, with the aid of the elongation factor 1-GTP (EF-1-GTP) complex.  
The GTP is hydrolyzed and EF-1 is released.  The specificity of the tRNA that 
binds is dependent on the template codon because the codon on the mRNA 





















Figure 1.1 Three step process of protein synthesis 
Initiation involves all of the components involved in protein synthesis coming 
together in an ordered manner.  The small ribosomal subunit interacts with 
the mRNA and initiator tRNA before the large subunit is recruited (A) 
Elongation involves the incorporation of amino acids into the polypeptide 
chain by the repetition of multiple steps (B).   Termination occurs when the 
stop codon enters the reading frame.  This initiates hydrolysis of the 







































A transfer reaction occurs in which the polypeptide chain on the tRNA 
in the P site is transferred to the tRNA in the A site.  This peptidyltransferase 
reaction is catalyzed by the large subunit of the ribosome.  The NH2 group of 
the amino acid bound to the aminoacyl-tRNA performs a nucleophilic attack 
on the carboxyl group of the amino acid on the peptidyl-tRNA.  This reaction 
results in a peptide bond forming between the peptide chain and the amino 
acid.  The deacylated tRNA in the P site is ejected from the ribosome and the 
newly formed peptidyl-tRNA is translocated from the A site to the P site.  
Simultaneously, the ribosome shifts the distance of one codon from the 5’ 
towards the 3’ on the mRNA revealing a new codon in the empty A site.  
Elongation factor-2 (EF-2) complexed with GTP catalyzes this translocation 
reaction and again, hydrolysis of GTP results in the release of EF-2.  Each 
time this sequence is repeated, one amino acid is added to the polypeptide 
chain with the consumption of one molecule of aminoacyl-tRNA, two 
molecules of GTP and two water molecules.   
Termination occurs as a result of a stop codon on the mRNA moving 
into the reading frame.  The stop codon does not have a cognate aminoacyl-
tRNA; therefore the polypeptide chain is ended.  The presentation of the stop 
codon in the reading frame attracts proteins called release factors.  Their 
function is to bind to the ribosome and induce hydrolysis of the polypeptide 
from the peptidyl-tRNA in the P site.  In eukaryotes, there is one release 
factor, RF1, which recognizes all of the potential stop codons, UAA, UAG or 
UGA.  It appears that the RF1 simulates tRNA binding in the A site.  Instead 
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of an amino acid from the aminoacyl-tRNA performing a nucleophilic attack 
on the peptidyl-tRNA polypeptide, a water molecule performs the attack.  This 
hydrolysis reaction releases the polypeptide chain. RF1 is released as a 
result of GTP hydrolysis followed by the release of the final deacylated tRNA.  
The ribosome subunits dissociate as can be seen in Panel C of Figure 1.3 [3, 
4]. 
 
The Reported Changes of Ribosomes and Ribosomal Proteins 
Although the rRNA is the catalyst in the synthesis of polypeptide 
chains, ribosomal proteins still have an important function by providing the 
structure for the rRNA.  Changes in the ribosome have been observed on 
different levels.  For instance, the observation was made that the number of 
active ribosomes per cell differed as a result of drug resistance [18].  
Eukaryotic ribosomal proteins are encoded by more than one gene, indicating 
that multiple isoforms of the proteins can exist and have been shown to be 
present in 80S ribosomes [19].  The particular protein isoforms present in the 
ribosome depends in part on the developmental stage of the organism.   
It has been demonstrated that the protein complement of ribosomes is 
heterogeneous for a specific organism, depending on the functionality and 
tissue of origin [20, 21].  In addition, a myriad of reports exist on the 
differential gene expression of ribosomal proteins [22-28] as well as altered 
abundance of ribosomal proteins [29, 30] in diseased states.  While increased 
expression or abundance of ribosomal proteins may not indicate a change in 
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the structure of the ribosome, it does indicate a potential deregulation of the 
very coordinated process of ribosomal protein synthesis.   
Ribosomal proteins have also been observed to change in both 
abundance and structure in antibiotic resistant bacteria [31].  Gregory and 
Dahlberg showed that alterations in ribosomal proteins are responsible for 
erythromycin resistance in E. coli even though the proteins had no direct 
contact with the drug [32].  It was determined that resistance was conferred 
through perturbation of the surrounding 23S rRNA as a result of the protein 
changes.  Large subunit ribosomal protein mutations have been observed as 
a result of resistance to a drug that induces frameshifting of the mRNA on the 
small subunit [33].  This indicates that the change in structure of the 
ribosomal proteins of the large subunit create conformational rearrangements 
of the small subunit. 
Ribosomal proteins are known to be heavily altered by such post-
translational modifications (PTM) as: methionine loss, N-terminal acetylation; 
lysine acetylation; methylation and phosphorylation [33-42].  It is unclear, 
however, what role the post-translational modifications play in ribosomal 
proteins.  In a few cases, PTM’s are known to be regulated by developmental 
stage.  These include the reduction in the number of glutamic acid residues 
on the C-terminus of ribosomal protein S6 [15].  Another example is the 
phosphorylation state of RPS6.  This modification is thought to regulate cell 
growth because the number of phosphorylations on the protein is proportional 
to the level of protein synthesis [43].  The phosphorylation of RPS6 is coupled 
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to extracellular signaling pathways, which are deregulated in cancer cells [44, 
45].   
 
Proteomics 
In order to study protein changes in a complex such as the ribosome, 
traditional biochemical techniques would be time consuming because one 
protein is analyzed at a time.  Proteomic methods are more efficient because 
they are designed to characterize many proteins at one time.  The term 
“proteome” refers to the dynamic protein complement of the genome, which is 
static.  The proteins expressed in a cell change depending on the stage of 
growth and function of the cell.  In addition, the DNA sequence does not 
predict post translational modifications or processing that proteins may 
experience to alter activity.  Although it has been determined that the human 
genome consists of 25,000 genes, with alternative splicing and post 
translational modifications, it is estimated that over 100,000 populations of 
proteins exist in the cell [46].   
The proteome is a theoretical set of proteins, because it is impossible 
to determine all of the proteins present in a cell at one time.  Sample 
complexity, dynamic range of the concentrations of the proteins and a lack of 
technology are among the challenges.  The dynamic range of the proteins in 
a cell varies greatly.  Some proteins are present in just a few copies per cell, 
whereas others are present in as high as 106 copies per cell [46].    
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Fractionating the proteins of a cell is one way of reducing the sample 
complexity.  Many types of fractionation have been employed in proteomic 
studies, such as various liquid chromatographic methods and subcellular 
fractionation.  Subcellular fractionation allows the global cellular changes as a 
result of acquired drug resistance to be determined by studying one fraction 
at a time.   The end result is the ability to hypothesize cellular mechanisms 
based on changes in the individual fractions.  The issue of dynamic range can 
be addressed by fractionating as well, but other strategies such as removal of 
extremely abundant proteins will allow the less abundant proteins to be 
detected.   
Comparative proteomics is a useful method in which a control state 
can be compared to an altered state of a system in order to find differences 
that result.  For example, in this work on acquired drug resistance, a drug 
susceptible cell line is the control state, while a drug resistant cell line is the 
altered state.  The protein differences that are discovered between the two 
may give insight into the mechanisms of drug resistance.  The proteins are 
evaluated on two different levels: the relative abundance of the protein and 
the post-translational modification changes of the proteins.  The scheme for 
identifying post-translational modifications can be seen in Figure 1.2. 
 
Two-Dimensional Gel Electrophoresis 
 
Modern two-dimensional polyacrylamide gel electrophoresis (2DGE) is 
a method in which proteins are separated in the first dimension by their 
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isoelectric point and in the second dimension by molecular weight.  This two-
dimensional separation provides better resolution of individual proteins from 
complex mixtures than methods such as 1D gels or liquid chromatography.  
2DGE is a powerful technique because a visual comparison can be made 
between the control and experimental gels.   This visual comparison gives the 
ability to compare abundance profiles and determine differences in the 
profiles. 
When 2DGE was applied to the ribosomal proteins, both the first and 
second dimension separated the proteins based on charge.  This elicited a 
diagonal pattern of protein spots.  A method was introduced by O’Farrell in 
1975 in which the proteins were separated by charge in the first dimension, 
as before [47].  The second dimension included the addition of sodium 
dodecyl sulfate in order to remove the charge differences of the proteins as a 
variable and separate proteins based on molecular weight.  This optimization 
improved the resolution of the proteins even further.  In addition to allowing 
more proteins to be separated in one experiment, the effective area of the gel 
was increased.   
The introduction of immobilized pH gradient (IPG) strips for isoelectric 
focusing, which create a gradient with a resolution of 0.001 pH units, also 
contributed greatly to the reproducibility and resolution of the proteins [48].   
Performing 2DGE on ribosomal proteins presents a unique challenge 
because of the basicity of the proteins.  A number of reasons contribute to the 
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Most involve the isoelectric focusing step of the first dimension.  
Reducing agents are added to the buffer to keep the proteins reduced.  Often 
times, the reducing agent migrates toward the anode of the focusing chamber 
depleting the cathode end of reducing agent.  The proteins are therefore 
susceptible to both inter and intra-molecular oxidation.  This effect results in 
horizontal streaking due to the many populations of proteins with different 
disulfide bonds.   
 
Mass Spectrometry 
Mass spectrometry is a method in which the mass of an analyte can be 
determined giving valuable information on the structure of the analyte.  The 
mass spectrometer can be separated into 3 regions: an ionization source, an 
analyzer and a detector.  The source ionizes the analyte so that it can be 
detected as well as vaporizing it so that it can be separated in a vacuum by 
the analyzers.  The analyzer separates the charged, airborne analytes based 
on their m/z, where m is the mass and z is the charge of the analyte.  The 
detector converts the electronic signal that results from the charged, m/z 
separated analytes colliding with the detector plate into a mass spectrum.   
Mass spectrometry became an integral tool for protein studies in the 
late 1980’s with the invention and application of the matrix-assisted laser 
desorption ionization mass spectrometry (MALDI-MS) and electrospray 
ionization mass spectrometry (ESI-MS) techniques.  These methods are able 
to generate large molecular weight ions.  They produce volatile ions of non-
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volatile biomolecules, such as proteins, allowing the biomolecule to remain 
intact during ionization, separation and detection.   
The presented work was performed on two different types of mass 
spectrometers, which will be discussed briefly.  The configuration of the 
Applied Biosystems Q-star Pulsar i can be seen in Figure 1.3.  Electrospray 
ionization was first applied to mass spectrometry of large biomolecules by 
Nobel laureate John Fenn in 1989 [57].  The analyte is mixed in a conducting 
solution, which is then sprayed across a high potential from a conducting 
metal-coated needle.   
The solution forms fine droplets which contain solvent and analyte, leaving 
the gaseous analyte ions.  ESI often produces analytes which are multiply 
charged as a result of multiple protonations or deprotonations.   
The Q-star can be operated in different modes depending on the 
information sought.  In the scanning mode, the instrument scans all m/z ratios 
in a given range.  The ions introduced from the electrospray source travel 
through the two quadrupoles and are pulsed into the time-of-flight tube.  The 
m/z is related to the time it takes to reach the detector. Small ions reach the 
detector faster than large ones.   
The second mode, which is used to perform tandem mass 
spectrometry, is called product ion scanning.  In this case, a selected 
precursor ion is selected in the first quadrupole and subjected to collisionally 
induced dissociation using an inert gas in the second quadrupole.  The 






















Figure 1.3 Ion path in the quadrupole time-of-flight mass spectrometer 
High voltage is applied which creates fine mist containing analyte.  The 
solvent is evaporated leaving volatile ions.  Q0 focuses the ions, while Q1 
separates them. A collision cell surrounds Q2, which is used for tandem mass 
spectrometry.  The ions are accelerated into the time-of-flight region.  The 








The configuration of the Shimadzu AXIMA-CFR+ can be seen in Figure 
1.4.  Matrix assisted laser desorption ionization (MALDI) was introduced as a 
mass spectrometric ionization technique in 1988 by both Karas and 
Hillenkamp; and Tanaka [57-59].  In MALDI, a UV absorbing matrix is co-
crystallized with an analyte on a sample target plate.  A laser pulse is applied 
to the target and the analyte and matrix are desorbed creating gaseous 
molecules.  The analyte is ionized by protonation in collision with the laser 
activated matrix.  The ions are then pulsed into the time-of-flight tube and 
analyzed.   Ions formed by MALDI are generally singly charged.   
Tandem mass spectrometry can also be performed on the AXIMA 
using a method called post-source decay (PSD).  Larger molecules are 
unstable in the field free region of the time-of-flight tube.  Fragmentation 
occurs as a result of this instability.  The precursor ion is selected by allowing 
the ion package of interest to be transmitted through an ion gate.  Initially, the 
PSD ions of a certain precursor ion are traveling at the same velocity.  These 
ions are reaccelerated at the reflectron, which allows for their separation [60].  
    
Post Translational Modifications 
 
Post translational modifications (PTM’s) are alterations to a protein 
structure made enzymatically after the proteins are translated. Modifications 
can also be made co-translationally.  They include the covalent addition of 
small and large groups, disulfide bond formation, or the cleavage of a 























Figure 1.4 Schematic representation of matrix-assisted laser desorption 
ionization and flight path of the ions 
 
Ions are formed when the analyte and matrix molecules collide in the plume 
created by the laser.  The ions are then accelerated into the time-of-flight 
region, where they are separated based on their mass to charge ratio (m/z).  
Less kinetic energy is transferred to the larger ions therefore it takes longer 
for them to hit the detector.  This is observed in the hypothetical spectrum.   





Sample co-crystallized with matrix 













PTM’s contribute to the tertiary and quaternary structure of a protein, and 
affect its function.  Commonly observed effects of PTM’s are the alteration of 
the activity of the protein, localization of the protein within a system, turnover 
of the protein, and protein-protein interactions [61-71].  Proteomic methods 
have allowed the characterization of many proteins in one experiment.  
Initially these methods were applied to the identification of proteins, but now 
methods are being developed to characterize the modifications present on 
proteins.   
 
“Bottom-up” Proteomics 
The use of mass spectrometry as a tool for determining protein 
identification using peptides is termed “bottom-up” proteomics.  The idea is 
that the protein is cut apart, and from the bottom up, the pieces are put 
together to determine the sequence.  
Tandem mass spectrometry allows isolation of a tryptic peptide that 
can be fragmented in the instrument and the ionized pieces detected to 
determine the partial sequence of the peptide [72, 73].  Peptides most 
commonly break at the amide bond between amino acids, as illustrated in 
Figure 1.5. If the charge is retained on the amino-terminal fragment, it is 
called a “b” ion.  If the charge is retained on the carboxy-terminal fragment, it 
is called a “y” ion [74].  If multiple b and y ions are detected for a peptide, the 
sequence can be determined to help identify the peptide.  When this analysis 
 
 22
is performed for multiple peptides from a protein, that protein can be 
identified.    
 Using a bottom-up approach, PTM’s can be identified by the 
observation of a shift in the mass of a peptide.  For instance, if a protein is 
phosphorylated, the peptide containing the phosphate group will have an 
increase in mass of 80Da.  The phosphate group can be localized to a 
particular amino acid residue by mass shifts in the fragmentation pattern. 
These assessments can be made by the investigation, and some search 
programs attempt to accommodate PTM’s. In order for this approach to 
identify the PTM’s in a protein, the modified peptide must be observed. 
Ideally, all peptides must be found to provide complete coverage of the 
protein sequence [75].  The greatest weakness of this method is that 
incomplete sequence coverage of the protein is usually obtained.  Commonly, 
not all proteolytic peptides are detected in the spectrum, which means that 
modifications or mutations can go undetected.   
Another approach has been devised to complement the “bottom-up” 




“Top-down” proteomics is a more recent application for determining 
























Figure 1.5 Dominant fragmentation pattern of a peptide and the resultant 
hypothetical mass spectrum 
 
Tandem mass spectrometry fragments proteolytic peptides in the gas phase.  
In the Q-star, this is achieved with collision induced dissociation (CID).  In the 
AXIMA, this is achieved using post source decay.  In both cases, the amide 
bond is most commonly broken.  If the amino-terminal fragment retains the 
charge, it is termed a “b” ion.  If the carboxy-terminal fragment retains the 
charge, it is termed a “y” ion.  
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mass spectrometer and an intact molecular weight is determined.  The intact 
protein is then fragmented in the mass spectrometer [75-84].  The intact 
molecular weight of the protein can indicate the presence of post-translational 
modifications or mutations in the primary sequence if it varies from the 
calculated molecular weight.  The molecular weights of the fragments localize 
the position of any modifications in the structure of the protein.  
A method that is receiving considerable attention currently for the 
identification and localization of PTM’s integrates top-down, bottom up 
approaches [38, 41, 85].  In this case, the protein is identified by peptide 
analysis (bottom up). Next the intact molecular weight of the intact protein is 
determined (top down) and compared to the theoretical molecular mass of the 
protein. Differences in mass may indicate the presence of modifications.  
Several computer programs are available [86, 87] to provide tentative 
identification of modifications. The modification is localized by gas phase 
fragmentation, bottom up.   
Obtaining 100% sequence coverage is difficult using either the top-
down or bottom-up approach [70].  In the bottom up approach, the peptides 
may be lost in the sample preparation steps preceding mass spectrometry.  In 
the top-down approach, the spectra are very complicated and not all of the 
fragment peaks are observed.  The methods are complementary, and 





Protein Identification and Bioinformatics 
The information generated from mass spectrometry experiments can 
be used to identify proteins using two approaches.  Both approaches involve 
the proteolytic digestion of a somewhat purified protein.  In peptide mass 
fingerprinting, a mass spectrum is generated in which the peaks in the 
spectrum correspond to ionized peptides which can be searched against a 
database to identify the protein.  This peptide map is often generated using a 
MALDI-TOF instrument because the generated spectra contain only singly 
charged peptides, which simplifies the search.  High sequence coverage, 
meaning a large representation of the sequence of the protein, must be 
obtained in order to unambiguously identify the protein using this method.  
The search engine compares the peptide list with peptide lists of in-silico 
digests products of the proteins in the specified database. A score is 
generated which reflects the probability that the observed match between the 
observed peaks with the theoretical peaks is a chance event [88, 89].     
Weaknesses of this approach are that the protein must be relatively pure.  In 
addition, it is possible to have peptides from two different proteins with the 
same molecular weight, which confounds identification of the protein.   
A second approach to protein identification involves acquiring tandem mass 
(MS/MS) spectrometry data.  In this method, a peptide is selected to be 
fragmented using either PSD or CID.  The fragments correspond to amino 
acid losses and the peptide can therefore be pieced back together to obtain a 
microsequence.  The microsequence or combination of microsequences is 
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then searched against the database for protein identification.  The spectra 
generated from CID are generally complicated, containing many y and b ions, 
as well as ions that result from other fragmentation patterns.  The most facile 
method of identifying the protein is to submit the MS/MS spectra to a search 
engine.  The search engine scans against protein sequence databases using 
various algorithms which calculate theoretical mass spectra and the overlap 
between the experimental and theoretical spectra is compared.  A score 
which reflects the statistical significance of the match between the observed 

















Hypothesis and Objectives 
Understanding the mechanisms of acquired drug resistance can lead to better 
treatments for cancer and therefore better outcomes.  Ribosomes perform a 
critical function in the cell by synthesizing all of the proteins.  We hypothesize 
that characterizing the content and structure of the ribosomal proteins of drug 
susceptible and drug resistant MCF-7 cells will provide insight into the 
involvement of the ribosome in multidrug resistance.  With this hypothesis, we 
have the following aims: 
1. Determine a reproducible method for isolation and purification of 
ribosomal proteins 
2. Optimize 2D gels of ribosomal proteins so that protein changes can be 
observed and identify the proteins visualized in the array 
3. Perform a gel-based comparative study between drug susceptible 
MCF-7 cell line and mitoxantrone resistant MCF-7 cell line 
4. Characterize the protein isoforms which were determined to have 
altered abundances in the comparative study using both the “bottom-
up” and “top-down” mass spectrometric approaches 
5. Perform absolute quantification study to evaluate the number of 
ribosomes per cell in the drug susceptible MCF-7 cell line and 






Chapter 2: Materials and Methods 
 
Materials 
Parental and mitoxantrone resistant cell lines were provided by Dr. Ken 
Cowan at the National Institutes of Health, National Cancer Institute.  The DC 
protein assay kit, the Protean II pre-cast gels (8-16% Tris-HCl), and the Bio-
Safe coommassie blue were purchased from Bio-Rad (Hercules, California).  
The immobilized pH gradient strips (IPG 18cm pH 7-11), the IPG buffer were 
purchased from GE Healthcare (Piscataway, New Jersey).  The quick-seal 
ultracentrifuge tubes were purchased from Beckman Coulter (Fullerton, CA).   
Sequence grade modified porcine trypsin was obtained from Promega 
Corporation (Madison, Wisconsin).  Ammonium bicarbonate, calcium chloride, 
3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 
dithiothreitol (DTT), Eagle’s minimal media (MEM), fetal bovine serum, 
glycerol, iodoacetamide, magnesium chloride, penicillin streptomycin 
antibiotic solution, phosphate buffered saline (PBS), potassium chloride, 
sucrose, thiourea, trifluoroacetic acid (TFA), Trizma base, cell culture grade 
trypsin, sodium dodecyl sulfate (SDS), and urea were obtained from Sigma 
Aldrich (St. Louis, Missouri).   
Equipment 
The Optima LE-80K preparative ultracentrifuge and the DU 530 UV-Vis 
spectrophotometer were from Beckman Coulter (Fullerton, CA).  The 
 
 29
mechanical homogenizer was purchased from Kinematica (Littau, Lucerne 
(Switzerland)).  The protein isoelectric focusing cell was obtained from GE 
Healthcare (Piscataway, New Jersey).  The second dimension gel apparatus 
and the GS-800 densitometer were obtained from Bio-Rad (Hercules, 
California). The hematocytometer and cover slips were purchased from 
Hauser Scientific (Horsham, PA).  The Alphashot-2 YS-2 microscope was 
from Nikon (Japan).  The speed-vac was from Thermo-Savant (Holbrook, 
NY).  The electrospray ionization mass spectrometer was from Applied 
Biosystems (Foster City, CA), and the matrix-assisted laser desorption 
ionization mass spectrometer was from Shimadzu Corporation (Nishinokyo-
Kuwabara-cho, Nakagyo-ku, Kyoto (Japan)).   
Methods 
Cell Culture and Harvest 
All cell lines used in this work were cultured in house.  The cells were 
grown in 150 cm2 flasks (Corning Incorporated, Corning, New York) in Eagle’s 
Minimal Essential Media (MEM) supplemented with 10% fetal bovine serum 
and 1% penicillin streptomycin antibiotic solution.  The cells were sustained in 
an incubator at a temperature of 37°C with 5% carbon dioxide.  At confluence 
the cells were harvested.  Cells were washed with 15mL of 10mM phosphate 
buffered saline (PBS), followed by the addition of 3mL of cell culture grade 
trypsin.   After a five minute incubation period, 10mL of MEM was added to 
the flasks to stop tryptic activity by changing the pH. Cells were suspended by 
repeatedly pipetting the solution up and down while rinsing the walls.  The 
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suspension was transferred to pre-weighed centrifugation tubes and 
centrifuged at 500g for 5 min.  The cell pellet was washed by resuspending 
two times with PBS followed by centrifugation.  The cell pellet was weighed 
and subjected to subcellular fractionation. 
 
Isolation of Ribosomes and Extraction of Ribosomal Proteins 
Three methods were evaluated for the isolation of ribosomal proteins.  
The first method suggested suspension of the cell pellet in 3 volumes of 
homogenization buffer (20mM Tris-HCl, pH 7.5; 5mM MgCl2; 100mM KCl; 
5mM β-mercaptoethanol; 250mM Sucrose) [91].  The pellet was 
homogenized by 80 strokes of a chilled glass homogenizer.  The nuclei, 
mitochondria and cellular debris were removed by centrifugation at 12,000g 
for 10 minutes.  Triton X-100 was added to a final concentration of 1%, and 
mixed with the post-mitochondrial supernatant.  The mixture was layered over 
an equal volume of the homogenization buffer with 1.0M Sucrose and 
centrifuged at 260,000g for 2 hours at 4°C.   
In the second method [92], the cells were lysed using a lysis buffer 
containing 1% Triton X-100; 1% sodium deoxycholate; 5mM Tris-HCl, pH 7.5; 
1.5mM KCl; 2.5mM MgCl2.  The lysate was centrifuged at 12000g for 5 
minutes to remove the nuclei, mitochondria and cellular debris.  The 
supernatant is brought to 28mL of final volume, and placed in a Beckman 
Quick-Seal tube.  The mixture is underlayed with 6mL of Buffer A (20mM Tris-
HCl; 100mM KCl; 5mM MgCl2; 1mM DTT; 700mM Sucrose), followed by 6mL 
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of Buffer B (20mM Tris-HCl; 500mM KCl; 5mM MgCl2; 1mM DTT; 1.6M 
Sucrose).  This was centrifuged for 16 hours at 215,000g.   
The final method that was evaluated and used for all subsequent 
analyses did not contain any detergent, which is difficult to remove from the 
proteins [93].  The cell pellet was suspended in 2 volumes of homogenization 
buffer (50mM Tris-HCl, pH 7.5; 5mM MgCl2, 25mM KCl, 200mM Sucrose).  
The suspension was homogenized by 20 strokes in the Kinematica 
mechanical homogenizer.  The homogenate rested for 1 minute and was 
homogenized again for 20 strokes.  The nuclei, mitochondria and cellular 
debris were removed by centrifugation at 10,000g for 10 minutes.  
Homogenization was repeated on the resultant pellet and the supernatants 
were pooled.  The lysate was layered at a 1:1 (v/v) ratio over a 2M sucrose 
solution in the same buffer and subjected to centrifugation at 260,000g for 2 
hours.   
The ribosomal pellet was suspended in 1 ml of homogenization buffer 
without sucrose, and is made 10mM in MgCl2 by the addition of 5µL of 1M 
MgCl2 [92, 94].  This was followed by the addition of 0.7 volumes of ethanol.  
The ribosomes precipitate immediately, and the suspension was centrifuged 
at 7000 rpm for 10 minutes.  The supernatant was removed and the 
ribosomes were resuspended in 250µL of homogenization buffer with no 
sucrose, followed by the addition of 25µL of 1M MgCl2 and 550µL of glacial 
acetic acid.  Following a 45 minute incubation period, the precipitated RNA 
was removed by centrifugation at 10,000 rpm for 10 minutes.  The 
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supernatant was removed and placed in another tube with 4 volumes of 
acetone.  The proteins immediately precipitated, but the suspension was 
placed in the freezer at –20°C for 2 hours to facilitate complete precipitation of 
the proteins.  The mixture was centrifuged at 10,000 rpm for 10 minutes to 
pellet the proteins.  The proteins were washed by the addition of 1 mL of 
acetone and centrifuged again.  This wash step was repeated once.  
 
Two-Dimensional Gel Electrophoresis 
In order to insure a consistent amount of protein was loaded onto each 
gel, the Bio-Rad DC Protein Assay Kit (Hercules, CA) was used to determine 
protein concentration.  The first gels were run using 11cm first dimension 
strips with a linear pI range of 3-10.  At this time, 200µg of protein was loaded 
per gel.  The proteins were lined up vertically on basic side of the gel because 
they could not be resolved in the pI range.  At this point, first dimension strips 
with a non-linear pI range of 7-11 were evaluated.  Resolution of the proteins 
was achieved although the quality of the gels was still poor.  In an attempt to 
improve resolution, larger format, 18cm gels were used.  The spots were no 
longer running into each other.  Resolution of the proteins on the gel was 
further improved by using 50µg of protein per gel.   
The first dimension of separation was started by a one hour incubation 
of the protein sample with 320uL of rehydration solution, which contains 7M 
urea, 2M thiourea, 2% (w/v) CHAPS, 50mM DTT and 1% IPG buffer (GE 
Healthcare).  The rehydration solution was pipetted into the focusing tray and 
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the IPG strip (pI range of 7-11, GE Healthcare) was laid on top of the solution.  
An electrode wick saturated by 6µL of 15mM DTT was placed under the strip 
at the cathode end of the focusing tray, while an electrode wick saturated with 
6µL of deionized water was placed under the strip at the anode end of the 
tray.  The strip was overlaid with mineral oil to prevent burning and the strip 
was passively rehydrated for 12 hours. The proteins were focused for 60,000 
V-hr.   
Upon completion of the first dimension focusing, the IPG strip was 
removed from the focusing tray and placed in equilibration buffer containing 
0.375M Tris-HCl, pH 8.8, 6M Urea, 20% Glycerol, 2% sodium dodecyl sulfate 
(SDS) and 2% DTT for 10 minutes.  The strip was removed from this buffer 
and placed in the same buffer without DTT, but containing 2.5% 
iodoacetamide for 10 minutes.  The strip was placed on top of an 8-16% Tris-
HCl SDS-PAGE pre-cast gel (Bio-Rad, Hercules CA).  The strip was covered 
with agarose solution, running buffer was added, and current was applied as 
follows:  16mA for 30 minutes followed by 24mA for 5 hours.  When the 
second dimension was completed, the gel was removed from the glass plates 
and placed in 50% water, 45% methanol and 5% acetic acid for 45 minutes to 
“fix” the proteins in the gel.  The gel was then washed in water for 15 minutes 
followed by staining overnight by Bio-safe coomassie blue (Bio-Rad, 
Hercules, CA).  The next day, the gel was destained by several water 






















Figure 2.1 Scheme of 2DGE 
The first dimension of this separation involves the migration of the proteins to 
their isoelectric point within an immobilized pH gradient (IPG).  In the second 
dimension, sodium dodecyl sulfate is added to remove the intrinsic charge of 
the protein so that this separation is based only on molecular weight of the 
protein.  In the first dimension, 7 spots are observed.  In the second 
dimension, 11 spots are observed, so 4 more proteins were resolved using a 
























Figure 2.2 Comparison of 2D gels from using the Compugen Z3 program 
Three gels were run for each of three harvests from each of the cell lines.  
The images of the three gels from one harvest were registered, resulting in 
one image.  The registered image of the harvest 1 gels of the parental cell 
line was then overlaid with the registered image from harvest 1 of the 
mitoxantroneR cell line, and the spots were matched.  This was repeated two 
times using the registered images from the other two harvests.  Red circles 
indicate the presence of the protein only in the drug resistant cell line.  The 
yellow circle indicates a decrease in relative abundance in the drug resistant 




Image Analysis and Comparative Densitometry 
Images of the two-dimensional gels were obtained using a GS-800 
densitometer and its associated software, PDQuest.  Once the gels were 
scanned, the images were saved as TIFF files.  Image analysis was 
performed after importing the TIFF files into the Compugen Z3 software as 
shown in Figure 2.2 (Compugen Limited, Tel Aviv, Israel).   
Each gel image was registered and the spot intensities were measured 
and recorded.  Three gel images from a harvest were overlaid and registered 
and saved as an image.  The spot intensities were normalized between the 
images for differences in protein loading. This was also done for the drug 
resistant cell line. For comparative analysis, three gel pairs were evaluated. 
The pair of images was overlaid and the spots were matched as can be seen 
in Figure 2.2.  The difference in the abundance between homologous spots in 
the two cells lines was calculated based on the quotient of their relative 
abundance in each gel.   Spots with a differential abundance greater than a 
factor of two were considered to be physiologically relevant.   
 
In-Gel Digestion and Desalting 
 
In-gel digestion was performed using the method of Schevchenko et al. 
[95].  Once the gel was imaged, the spots were excised and placed into 
microcentrifuge tubes.  The gel pieces were washed by alternately adding 
and removing water followed by water/acetonitrile (1:1) for 15 minutes each.  
Acetonitrile was added until the gel pieces shrunk and became white.  
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Following the removal of the acetonitrile, the gel pieces were rehydrated in 
0.1M NH4HCO3 for 5 minutes.  An equal volume of acetonitrile was added 
and incubated for 15 minutes.  All of the liquid was removed and the gel 
pieces were dried down in a vacuum centrifuge.  These washing steps were 
performed to remove the coomassie blue stain in the gel pieces.   
The proteins were reduced by the addition of 10mM DTT in 0.1M 
NH4HCO3 to the dehydrated gel pieces following a 45 minute incubation at 
56°C.  The microcentrifuge tubes were allowed to come to room temperature 
and the excess liquid was removed.  The proteins were alkylated by the 
addition of 55mM iodoacetamide in 0.1M NH4HCO3 for a 30 minute room 
temperature incubation in the dark.  The iodoacetamide solution was removed 
and the gel washing steps were repeated to remove any residual stain and 
DTT and iodoacetamide from the gel pieces.   
The gel pieces were dried down in the vacuum centrifuge and then 
rehydrated by the addition of digestion buffer (50mM NH4HCO3, 5mM CaCl, 
12.5 ng/µL trypsin).  The gel pieces were incubated for 45 minutes on ice 
while rehydrating.  Any remaining solution is removed and replaced with a 
small volume of digestion buffer without the enzyme.  The gel pieces were 
incubated overnight at 37°C.   
The following day, 25mM NH4HCO3 was added and the gel pieces 
were incubated for 15 minutes.  The same volume of acetonitrile was added 
and again incubated for 15 minutes.  The supernatant was recovered and the 
extraction was repeated two times with the addition of 5% formic acid with a 
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15 minute incubation, followed by the addition of an equal volume of 
acetonitrile and another 15 minute incubation period.  The extracts from each 
spot were pooled and dried down in a vacuum centrifuge.  
  The peptides were resuspended in 0.1% TFA and desalted using a C18 
ZipTip (Millipore, Bedford, MA).  Briefly, the tip was equilibrated by twice 
aspirating and then dispensing 50% acetonitrile, followed by twice aspirating 
and then dispensing 0.1% TFA.  The peptides were bound to the column by 
aspirating then dispensing the peptide mixture for 7-10 cycles.  The salts 
were removed by washing with 0.1% TFA two times.  The peptides were 
eluted by aspirating and then dispensing 0.1% TFA/50% acetonitrile for 3-5 
cycles. The peptides were dried down and resuspended in electrospray 
solution (49% water/49% methanol/2% acetic acid).  If the peptides were to 
be analyzed by the MALDI instrument, they were spotted directly on the 
MALDI plate in the elution solution.   
 
Mass Spectrometry 
The peptides were either analyzed on the Shimadzu AXIMA CFR+ 
MALDI with a nitrogen laser at a wavelength of 337nm, or on the Applied 
Biosystems Q-star Pulsar I using the Protana static nanospray source 
(Odense, Denmark).  To obtain spectra from the AXIMA, 1-2µL of sample was 
applied to the MALDI target and allowed to dry.  The matrix used for peptides 
was 5 mg/ml alpha-cyano and 1µL was applied to the dried sample.  The 
AXIMA was set to scan from m/z range of 0-5000 using reflectron mode for 
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MS analysis.  The laser power was set at 45 (arbitrary units), and 100 profiles 
were averaged at 10 laser shots per profile.   Once the TOF spectrum was 
acquired, peptides were selected for post source decay (PSD) analysis or 
tandem mass spectrometry based on their intensity.  If the intensity of the 
peptide was above 100mV, the quality of the PSD spectrum was good 
enough to provide reliable protein identification.  PSD spectra were acquired 
by setting the ion gate to pass ions 5 m/z units above and below the m/z of 
the peptide of interest.  The laser power ranged from about 50-60 (arbitrary 
units).   
The Q-star instrument was set to scan m/z range 300-2000 for the MS 
analysis.  In order to obtain the spectra, 2µL of the suspended peptides in 
electrospray solution were put into the capillary tip (Protana, Odense, 
Denmark), and sprayed into the instrument with the following parameters: the 
curtain gas was 25, the ionspray voltage was 900V and the detector was set 
at 2300 mV.  Once a peptide list was generated, tandem MS was performed.   
The parameter that changed for tandem mass spectrometry was the collision 
gas.  The amount of gas had to be modified based on the ease of 
fragmentation of the peptide.  The collision gas range was between 20-50 
(arbitrary units). 
   
Protein Identification 
A scheme for protein identification using peptide mass fingerprinting can be 






















Figure 2.3 Protein identification using peptide mass fingerprinting 
The protein is digested in the gel using trypsin.  The resultant peptides are 
extracted from the gel, desalted and analyzed by mass spectrometry.  The list 
of peptides is submitted to the MASCOT search engine using the SwissProt 
database.  MASCOT returns a list of candidate proteins.  A score greater than 
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Figure 2.4 Protein identification using Tandem MS 
The protein is digested in the gel using trypsin.  The resultant peptides are 
extracted from the gel, desalted and analyzed by mass spectrometry.  
Tandem MS is performed on peptides selected from the TOF spectrum (top).  









was submitted to the MASCOT search engine manually.  A scheme for 
protein identification using sequence tags can be seen in Figure 2.4.  A 
minimum of 2 multiply charged peptides were selected from the TOF 
spectrum and subjected to tandem mass spectrometry with either the AXIMA 
or the Q-star.  The resulting sequence tags as well as the masses of the 
peptides were submitted to the SwissProt database through the MASCOT 
search engine using the BioExplore software associated with the mass 
spectrometer.  MASCOT returned a list of candidate proteins with scores that 
represent a 95% confidence level associated with the potential identifications.   
 
Isolation of Protein Isoforms and Mass Measurement 
The scheme for intact molecular weight determination can be seen in Figure 
2.5.  The proteins from the spots of interest were extracted from the 2D gels 
using a method by Mirza et al [96].  The spots were cut from the fixed and 
stained gel and briefly washed with water.  To destain, the water was 
removed and 10% acetic acid was added for 10 minutes.  After acetic acid 
removal and water wash, the gel piece was washed in acetonitrile followed by 
methanol for 20 minutes each.  A solution of formic acid/water/isopropanol 
(1/3/2) was added and the tubes were vortexed until the gel piece was 
colorless.  The gel piece was washed in water then dehydrated by placing it in 
the speed-vac for 5 minutes.  Ten microliters of extraction solution, (50% 
























Figure 2.5 Intact molecular weight determination 
The protein was extracted from the gel using the method described by Mirza 
et al.  The protein was mixed with Triton X-100 and spotted on the MALDI 




MALDI analysis was performed on the extracted protein by mixing 1uL of the 
extract with 1uL of 5% Triton X-100.  The 2uL mixture was spotted on the 
MALDI plate using the sandwich method with 10mg/mL of sinapinic acid in 
50% ACN/1% TFA.  The sandwich method entails spotting the matrix, letting 
it dry.  The sample is then spotted on the plate and allowed to dry, followed by 
another spot of matrix.  The settings for the instrument were as follows:  linear 
mode; mass range was 10,000-40,000; laser power 100-105; and 250 profiles 
were averaged.   
 
Absolute Quantification 
Absolute quantification of the number of ribosomes in a cell was 
performed on both the parental MCF-7 cell line and the mitoxantrone resistant 
MCF-7 cell line. Three flasks of each cell line were grown to confluence.  The 
cells were harvested as described earlier with careful attention to the amount 
of trypsin and media added in the last two steps.  A 100µL aliquot was 
removed from the mixture of the suspended cells and used for cell counting.  
A hematocytometer was used to count the cells in the aliquot and calculate 
the total number of cells per harvest.  The glass cover slip was placed on top 
of the hematocytometer and 6µL of suspended cells was placed under the 
cover slip.  Using a microscope, the number of cells was counted manually in 
each square and all 16 squares were added together.  The counting was 
repeated in another 16-square grid and the two values were averaged.  This 
was repeated for two additional harvests for each cell line for a total of three 
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harvests per cell line.  The averaged number was multiplied by 10,000 to give 
the number of cells per mL.   
The isolation of ribosomes was performed as described above.  
Following centrifugation through the sucrose cushion, the pellet was 
recovered and the ribosomes were precipitated using ethanol as above.  They 
were resuspended in water for optical density measurements.  Using a 
Beckman DU 530 UV-Vis spectrophotometer, the OD260 measurements were 
taken with 4 replicate measurements each at a 1X concentration and a 0.5X 
concentration.  The widely accepted conversion factor of, 1 OD260 unit is 
equal to 19 pmol of ribosomes [97], was used to calculate the total number of 
ribosomes per harvest.  By determining the total number of cells per harvest 
and the total number of ribosomes per harvest, the total number of ribosomes 
per cell could be calculated.   
 
Error Analysis 
The number of cells per harvest as well as the number of ribosomes 
per harvest was calculated for each harvest.  The number of ribosomes per 
cell was then calculated for each harvest and the standard deviation was 




















Where sx is the standard deviation of the calculated value of the number of 
ribosomes per cell (x); sc is the standard deviation of the cell count (c) and sr 
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is the standard deviation of the measurement of the number of ribosomes per 
harvest (r).   
While individual error bars are informative, they do not convey the 
inter-relatedness of datasets in a quantitative way.  The ANOVA (analysis of 
variance) function can statistically compare the variation between groups.  In 
this case, since two populations are being tested repeatedly, the two-factor 
ANOVA with replication was performed.  This test was applied to compare the 
cell count between the parental and drug resistant cell lines; to compare the 
absorbances between the parental and drug resistant cell lines and to 
compare the calculated values of the number of ribosomes per cell for both 












Chapter 3: Results 
Reproducible Method for Isolation and Purification of Ribosomal 
Proteins 
Three methods for ribosome isolation were evaluated for purity.  Figures 3.1-
3.3 show the gels and list of proteins identified from each of the methods.  In 
method one, of the 27 proteins which were identified, 24 were ribosomal.  In 
method two, of the 24 proteins that were identified, 22 were ribosomal.  In 
method three, of the 31 proteins that were identified, 29 were ribosomal.   
 
Optimization of 2DGE and Protein Identification 
In this research, 2D gel electrophoresis and mass spectrometry are used to 
identify the ribosomal proteins as well as the post translational modifications 
and protein isoforms present in the ribosome of both the MCF-7 parental and 
drug resistance cell lines.  Ribosomal proteins are known to be extremely 
basic and therefore do not resolve well in the first dimension of 2D gel 
electrophoresis.  Multiple optimization steps were performed in order to 
produce reproducible gels in which the proteins were well resolved.  The use 
of “zoom” isoelectric focusing strips, which have a pI range of 7-11, result in 
better resolution of the proteins than the wide range strips.  Secondly, the 
amount of protein loaded on the gel was greatly reduced from the amount 
recommended in standard procedures.  In many cases, a very complex 
sample mixture is applied to a gel, so the standard amount of 200ug of 













Figure 3.1 Evaluation of method 1 for isolation of ribosomal proteins 
The gel was run with ribosomal proteins extracted using method 1.  The 
protein list shows that 24 ribosomal proteins were identified.  Three non-

































 Protein Name MW (Da) PI # of peptides matched Mascot Score 
1 60S ribosomal protein L3 45440 10.16 4 99 
2 40S ribosomal protein S3a 29795 9.75 6 212 
3 60S ribosomal protein L11 19981 9.64 4 70 
4 40S ribosomal protein S17 15409 9.85 3 67 
5 60S ribosomal protein L10 24430 10.11 4 126 
6 40S ribosomal protein S4, X isoform 29448 10.16 9 124 
 40S ribosomal protein S4, Y isoform 29306 10.25 4 75 
7 40S ribosomal protein S6 28663 10.85 6 159 
8 60S ribosomal protein L17 (L23) 21252 10.18 4 97 
9 40S ribosomal protein S20 13364 9.95 6 311 
10 40S ribosomal protein S9 22447 10.66 6 102 
11 40S ribosomal protein S5 22862 9.73 3 72 
12 40S ribosomal protein L37a 10137 10.44 2 89 
13 40S ribosomal protein S8 24509 10.32 7 140 
14 60S ribosomal protein L21 18422 10.49 7 199 
15 60S ribosomal protein L38 8082 10.10 2 62 
16 40S ribosomal protein S18 (KE-3) 17708 10.99 5 108 
17 60S ribosomal protein L10a (CSA-19) 24684 9.94 3 121 
18 60S ribosomal protein L8 27876 11.03 6 180 
19 40S ribosomal protein S11 18419 10.31 3 109 
20 40S ribosomal protein S15 16898 10.39 3 70 
21 40S ribosomal protein S25 13734 10.12 3 81 
22 40S ribosomal protein L27a 16420 11.00 2 65 
23 40S ribosomal protein S29 6541 10.17 4 132 
24 40S ribosomal protein S16 16304 10.21 2 65 
25 Histone H4 11229 11.36 4 208 
26 Histone H3 15187 11.27 5 96 
























Figure 3.2 Evaluation of method 2 for isolation of ribosomal proteins 
The gel was run with ribosomal proteins extracted using method 2.  The 
protein list shows that 21 ribosomal proteins were identified.  Three non-































 Protein Name MW (Da) PI # of peptide matches Mascot Score 
1 60S ribosomal protein L3 45440 10.16 13 281 
 60S ribosomal protein L3-like 46136 10.45 4 69 
2 40S ribosomal protein S3a 29795 9.75 7 202 
3 60S ribosomal protein L11 19981 9.64 3 104 
4 40S ribosomal protein S17 15409 9.85 2 70 
5 60S ribosomal protein L10 24430 10.11 4 98 
6 40S ribosomal protein S4, X isoform 29448 10.16 4 123 
7 40S ribosomal protein S6 28663 10.85 4 109 
8 60S ribosomal protein L17 (L23) 21252 10.18 3 76 
9 40S ribosomal protein S20 13364 9.95 4 84 
10 40S ribosomal protein S9 22447 10.66 3 112 
11 Polyadenate Binding Protein-1 61142 9.12 11 372 
12 60S ribosomal protein L6 32577 10.59 11 271 
13 60S ribosomal protein L5 34295 9.76 4 139 
14 FK506-binding protein 3 25161 9.29 2 78 
15 60S ribosomal protein L22 14647 9.22 2 104 
16 40S ribosomal protein S3 26671 9.68 2 119 
17 60S ribosomal protein L12 17808 9.48 2 69 
18 40S ribosomal protein S7 (S8) 22113 10.09 2 62 
19 60S ribosomal protein L30 12645 9.65 3 136 
20 60S ribosomal protein L7a 29846 10.61 5 120 
21 60S ribosomal protein L14 23160 10.94 3 130 
22 DNA binding protein A 40036 9.77 1 102 
23 60S ribosomal protein L7 29207 10.66 3 83 
























Figure 3.3 Evaluation of method 3 for isolation of ribosomal proteins 
The gel was run with ribosomal proteins extracted using method 3.  The 
protein list shows that 29 ribosomal proteins were identified.  Two non-


































 Protein Name MW (Da) PI # of peptide matches Mascot Scores 
1 60S ribosomal protein L3 45440 10.16 4 161 
2 40S ribosomal protein S3a 29795 9.75 3 102 
3 60S ribosomal protein L11 19981 9.64 8 (PMF) 92 
4 40S ribosomal protein S17 15409 9.85 10 (PMF) 98 
5 60S ribosomal protein L10 24430 10.11 3 146 
6 40S ribosomal protein S4, X isoform 29448 10.16 3 103 
7 40S ribosomal protein S6 28663 10.85 3 123 
8 60S ribosomal protein L17 (L23) 21252 10.18 11 (PMF) 124 
9 40S ribosomal protein S20 13364 9.95 3 170 
10 40S ribosomal protein S5 22862 9.73 2 67 
11 40S ribosomal protein L37a 10137 10.44 3 103 
12 40S ribosomal protein S8 24509 10.32 8 (PMF) 88 
13 60S ribosomal protein L21 18422 10.49 4 160 
14 Polyadenate Binding Protein-1 61142 9.12 4 164 
15 60S ribosomal protein L6 32577 10.59 3 79 
16 60S ribosomal protein L5 34295 9.76 3 108 
17 FK506-binding protein 3 25161 9.29 2 94 
18 60S ribosomal protein L22 14647 9.22 2 111 
19 40S ribosomal protein S3 26671 9.68 3 163 
20 60S ribosomal protein L12 17808 9.48 6 74 
21 40S ribosomal protein S7 (S8) 22113 10.09 2 70 
22 60S ribosomal protein L30 12645 9.65 3 135 
23 60S ribosomal protein L7a 29846 10.61 4 118 
24 60S ribosomal protein L14 23160 10.94 3 134 
25 Nuclease sensitive binding protein-1 35903 9.87 4 85 
26 40S ribosomal protein S2 (S4) 31305 10.25 3 87 
27 60S ribosomal protein L44 (L36a) 12302 10.59 2 73 
28 60S ribosomal protein L35a 12530 11.07 4 194 
29 60S ribosomal protein L9 21850 9.96 11 (PMF) 100 
30 60S ribosomal protein L29 17610 11.66 3 100 




Since the ribosome was enriched, the mixture of proteins is relatively simple.  
The protein amount can therefore be reduced leading to a much better 
resolution but still providing enough material to identify the proteins.  Lastly, a 
DTT wick was applied to the cathode end of the focusing chamber.  DTT 
migrates toward the anode during focusing, allowing the proteins left behind 
to be oxidized.  The DTT supplied by the wick allows a constant supply of 
DTT to keep the proteins in the basic end reduced during isoelectric focusing.  
These optimization steps allowed for good resolution of the basic ribosomal 
proteins, which can be seen in Figure 3.4.   
The ribosomal proteins were separated by 2DGE and the images were 
recorded.  Figure 3.5 shows an annotated gel containing numbered protein 
spots which represent the spots that were cut, digested and subjected to 
mass spectrometry for identification.  The proteins were identified by peptide 
mass fingerprinting or microsequencing.   
At least 5 peptide mass matches in addition to a MASCOT score that 
allowed >95% confidence, were required for positive protein identification 
using peptide mass fingerprinting.  A minimum of two sequence tags in 
addition to a significant MASCOT score were required for positive protein 
identification using the microsequencing technique.  Fifty-one proteins were 
identified.  Forty-nine were ribosomal proteins, while two are classified as 
ribosomal associated proteins.  Table 3.1 shows the list of proteins identified 



























Figure 3.4 Comparison of 2D gel of ribosomal proteins before and after 
optimization 
The picture on the left shows ribosomal proteins that are close together and 
there are many pairs of spots.  The use of a large format gel allowed for 
better separation of the proteins.  The DTT wick resulted in one population of 

















































































# Protein (Isoform) Name MW PI Sequence Tags Mascot Score
1 Polyadenylate Binding Protein 70626 9.52 12 308 
2 RPL3 45949 10.19 11 281 
3 RPL6 32577 10.59 2 60 
4 RPL5 34295 9.76 2 59 
5 RPS3a 29795 9.75 4 72 
6 RPS3 26671 9.68 10 635 
7 RPS3 26671 9.68 9 556 
8 RPS3 26671 9.98 5 288 
9 RPS4X 29448 10.16 5 162 
10 RPL10a 24684 9.94 5 351 
 RPL13 24115 11.65 3 148 
11 RPL7a 29207 10.66 6 210 
12 RPS6 28663 10.85 3 123 
13 RPL8 27876 11.03 6 180 
14 RPL7 29207 10.66 3 83 
15 RPS8 24059 10.32 5 228 
16 RPL14 23144 10.94 3 81 
17 RPS2 31305 10.25 5 193 
18 RPL10 24430 10.11 7 200 
19 RPL13a 23431 10.94 3 83 
20 RPL9 21850 9.96 4 149 
21 RPS5 22731 9.73 5 223 
22 RPS9 22447 10.66 3 125 
23 RPL21 18422 10.49 2 79 
24 RPL17 (L23) 21252 10.18 3 114 
25 RPL11 20109 9.64 2 117 
26 RPL12 17808 9.48 3 95 
27 RPL26/RPS26-like 1 17246 10.55 5 165 
28 RPS11 18419 10.31 4 121 
29 RPS10 18886 10.15 3 281 
30 RPS15 16898 10.39 2 125 
 RPS16 16304 10.21 3 144 
 RPL27 15657 10.56 3 113 
 RPS25 13734 10.12 2 109 
 RPS15a 14699 10.14 5 224 
  
 






# Protein (Isoform) Name MW PI Sequence Tags Mascot Score
31 RPS25 13734 10.12 4 138 
32 RPS17 15409 9.85 5 282 
33 RPS18 17708 10.99 7 235 
34 RPS13 17081 10.53 5 149 
35 RPL27 15657 10.56 5 173 
36 RPL31 14454 10.54 5 166 
 RPS14 16131 10.08 1 73 
37 RPS16 16304 10.21 6 318 
38 RPS20 13364 9.95 4 124 
39 RPS10 18886 10.15 4 88 
40 RPL30 12645 9.65 4 161 
41 RPS19 16019 10.41 6 255 
 RPS15a 14708 10.61 3 96 
42 RPS15a 14708 10.61 3 98 
43 RPS10 18886 10.15 3 72 
44 RPL23 14856 10.51 5 118 
45 RP35a 12530 11.07 7 236 
46 RPL38 8082 10.10 2 62 
47 RPS29 6541 10.17 4 132 
48 RPL37a 10137 10.44 2 89 
49 RPL22 14647 9.22 2 104 
50 RPL36a 12302 10.59 2 73 
51 RPL24 17768 11.26 8-PMF 80 












Table 3.2 Sequence coverage of proteins using the bottom-up approach.   
# Protein Accession # Sequence Covered % 
2 RPL3 P39023 SHRKFSAPRH GSLGFLPRKR SSRHRGKVKS 
FPKDDPSKPV HLTAFLGYKA GMTHIVREVD  
RPGSKVNKKE VVEAVTIVET PPMVVVGIVG 
YVETPRGLRT FKTVFAEHIS DECKRRFYKN  
WHKSKKKAFT KYCKKWQDED GKKQLEKDFS 
SMKKYCQVIR VIAHTQMRLL PLRQKKAHLM  
EIQVNGGTVA EKLDWARERL EQQVPVNQVF 
GQDEMIDVIG VTKGKGYKGV TSRWHTKKLP  
RKTHRGLRKV ACIGAWHPAR VAFSVARAGQ 
KGYHHRTEIN KKIYKIGQGY LIKDGKLIKN  
NASTDYDLSD KSINPLGGFV HYGEVTNDFV 
MLKGCVVGTK KRVLTLRKSL LVQTKRRALE  
KIDLKFIDTT SKFGHGRFQT MEEKKAFMGP 
LKKDRIAKEE GA 
62% 
3 RPL6 Q02878 AGEKVEKPDT KEKKPEAKKV DAGGKVKKGN 
LKAKKPKKGK PHCSRNPVLV RGIGRYSRSA  
MYSRKAMYKR KYSAAKSKVE KKKKEKVLAT 
VTKPVGGDKN GGTRVVKLRK MPRYYPTEDV  
PRKLLSHGKK PFSQHVRKLR ASITPGTILI 
ILTGRHRGKR VVFLKQLASG LLLVTGPLVL  
NRVPLRRTHQ KFVIATSTKI DISNVKIPKH 
LTDAYFKKKK LRKPRHQEGE IFDTEKEKYE  
ITEQRKIDQK AVDSQILPKI KAIPQLQGYL 
RSVFALTNGI YPHKLVF 
79% 
4 RPL5 P46777 GFVKVVKNKA YFKRYQVKFR RRREGKTDYY 
ARKRLVIQDK NKYNTPKYRM IVRVTNRDII  
CQIAYARIEG DMIVCARYAH ELPKYGVKVG 
LTNYAAAYCT GLLLARRLLN RFGMDKIYEG  
QVEVTGDEYN VESIDGQPGA FTCYLDAGLA 
RTTTGNKVFG ALKGAVDGGL SIPHSTKRFP  
GYDSESKEFN AEVHRKHIMG QNVADYMRYL 
MEEDEDAYKK QFSQYIKNSV TPDMMEEMYK  
KAHAAIRENP VYEKKPKKEV KKKRWNRPKM 
SLAQKKDRVA QKKASFLRAQ ERAAES 
68% 
5 RPS3a P61247 AVGKNKRLTK GGKKGAKKKV VDPFSKKDWY 
DVKAPAMFNI RNIGKTLVTR TQGTKIASDG  
LKGRVFEVSL ADLQNDEVAF RKFKLITEDV 
QGKNCLTNFH GMDLTRDKMC SMVKKWQTMI  
EAHVDVKTTD GYLLRLFCVG FTKKRNNQIR 
KTSYAQHQQV RQIRKKMMEI MTREVQTNDL  
KEVVNKLIPD SIGKDIEKAC QSIYPLHDVF 
VRKVKMLKKP KFELGKLMEL HGEGSSSGKA  
TGDETGAKVE RADGYEPPVQ ESV 
83% 
6 RPS3 P23396 MAVQISKKRK FVADGIFKAE LNEFLTRELA 
EDGYSGVEVR VTPTRTEIII LATRTQNVLG  
EKGRRIRELT AVVQKRFGFP EGSVELYAEK 
VATRGLCAIA QAESLRYKLL GGLAVRRACY  
GVLRFIMESG AKGCEVVVSG KLRGQRAKSM 
KFVDGLMIHS GDPVNYYVDT AVRHVLLRQG  
VLGIKVKIML PWDPTGKIGP KKPLPDHVSI 






Table 3.2 Sequence coverage of proteins using the bottom-up approach 
# Protein Accession # Sequence Covered % 
7 RPS3 P23396 MAVQISKKRK FVADGIFKAE LNEFLTRELA 
EDGYSGVEVR VTPTRTEIII LATRTQNVLG  
EKGRRIRELT AVVQKRFGFP EGSVELYAEK 
VATRGLCAIA QAESLRYKLL GGLAVRRACY  
GVLRFIMESG AKGCEVVVSG KLRGQRAKSM 
KFVDGLMIHS GDPVNYYVDT AVRHVLLRQG  
VLGIKVKIML PWDPTGKIGP KKPLPDHVSI 
VEPKDEILPT TPISEQKGGK PEPPAMPQPV  
PTA 
67% 
8 RPS3 P23396 MAVQISKKRK FVADGIFKAE LNEFLTRELA 
EDGYSGVEVR VTPTRTEIII LATRTQNVLG  
EKGRRIRELT AVVQKRFGFP EGSVELYAEK 
VATRGLCAIA QAESLRYKLL GGLAVRRACY  
GVLRFIMESG AKGCEVVVSG KLRGQRAKSM 
KFVDGLMIHS GDPVNYYVDT AVRHVLLRQG  
VLGIKVKIML PWDPTGKIGP KKPLPDHVSI 
VEPKDEILPT TPISEQKGGK PEPPAMPQPV  
PTA 
48% 
9 RPS4X P62701 ARGPKKHLKR VAAPKHWMLD KLTGVFAPRP 
STGPHKLREC LPLIIFLRNR LKYALTGDEV  
KKICMQRFIK IDGKVRTDIT YPAGFMDVIS 
IDKTGENFRL IYDTKGRFAV HRITPEEAKY  
KLCKVRKIFV GTKGIPHLVT HDARTIRYPD 
PLIKVNDTIQ IDLETGKITD FIKFDTGNLC  
MVTGGANLGR IGVITNRERH PGSFDVVHVK 
DANGNSFATR LSNIFVIGKG NKPWISLPRG  
KGIRLTIAEE RDKRLAAKQS SG 
72% 
10 RPL10a P62906 SSKVSRDTLY EAVREVLHGN QRKRRKFLET 
VELQISLKNY DPQKDKRFSG TVRLKSTPRP  
KFSVCVLGDQ QHCDEAKAVD IPHMDIEALK 
KLNKNKKLVK KLAKKYDAFL ASESLIKQIP  
RILGPGLNKA GKFPSLLTHN ENMVAKVDEV 
KSTIKFQMKK VLCLAVAVGH VKMTDDELVY  
NIHLAVNFLV SLLKKNWQNV RALYIKSTMG 
KPQRLY 
72% 
 RPL13 P26373 APSRNGMVLK PHFHKDWQRR VATWFNQPAR 
KIRRRKARQA KARRIAPRPA SGPIRPIVRC  
PTVRYHTKVR AGRGFSLEEL RVAGIHKKVA 
RTIGISVDPR RRNKSTESLQ ANVQRLKEYR  
SKLILFPRKP SAPKKGDSSA EELKLATQLT 
GPVMPVRNVY KKEKARVITE EEKNFKAFAS  
LRMARANARL FGIRAKRAKE AAEQDVEKKK 
34% 
11 RPL7a P62424 PKGKKAKGKK VAPAPAVVKK QEAKKVVNPL 
FEKRPKNFGI GQDIQPKRDL TRFVKWPRYI  
RLQRQRAILY KRLKVPPAIN QFTQALDRQT 
ATQLLKLAHK YRPETKQEKK QRLLARAEKK  
AAGKGDVPTK RPPVLRAGVN TVTTLVENKK 
AQLVVIAHDV DPIELVVFLP ALCRKMGVPY  
CIIKGKARLG RLVHRKTCTT VAFTQVNSED 
KGALAKLVEA IRTNYNDRYD EIRRHWGGNV  





Table 3.2 Sequence coverage of proteins using the bottom-up approach 
# Protein Accession #          Sequence Covered % 
12 RPS6 P62753 MKLNISFPAT GCQKLIEVDD ERKLRTFYEK 
RMATEVAADA LGEEWKGYVV RISGGNDKQG  
FPMKQGVLTH GRVRLLLSKG HSCYRPRRTG 
ERKRKSVRGC IVDANLSVLN LVIVKKGEKD  
IPGLTDTTVP RRLGPKRASR IRKLFNLSKE 
DDVRQYVVRK PLNKEGKKPR TKAPKIQRLV  
TPRVLQHKRR RIALKKQRTK KNKEEAAEYA 
KLLAKRMKEA KEKRQEQIAK RRRLSSLRAS  
TSKSESSQK 
60% 
13 RPL8 P62917 GRVIRGQRKG AGSVFRAHVK HRKGAARLRA 
VDFAERHGYI KGIVKDIIHD PGRGAPLAKV  
VFRDPYRFKK RTELFIAAEG IHTGQFVYCG 
KKAQLNIGNV LPVGTMPEGT IVCCLEEKPG  
DRGKLARASG NYATVISHNP ETKKTRVKLP 
SGSKKVISSA NRAVVGVVAG GGRIDKPILK  
AGRAYHKYKA KRNCWPRVRG VAMNPVEHPF 
GGGNHQHIGK PSTIRRDAPA GRKVGLIAAR  
RTGRLRGTKT VQEKEN 
64% 
14 RPL7 P18124 MEGVEEKKKE VPAVPETLKK KRRNFAELKI 
KRLRKKFAQK MLRKARRKLI YEKAKHYHKE  
YRQMYRTEIR MARMARKAGN FYVPAEPKLA 
FVIRIRGING VSPKVRKVLQ LLRLRQIFNG  
TFVKLNKASI NMLRIVEPYI AWGYPNLKSV 
NELIYKRGYG KINKKRIALT DNALIARSLG  
KYGIICMEDL IHEIYTVGKR FKEANNFLWP 
FKLSSPRGGM KKKTTHFVEG GDAGNREDQI  
NRLIRRMN 
72% 
15 RPS8 P62241 GISRDNWHKR RKTGGKRKPY HKKRKYELGR 
PAANTKIGPR RIHTVRVRGG NKKYRALRLD  
VGNFSWGSEC CTRKTRIIDV VYNASNNELV 
RTKTLVKNCI VLIDSTPYRQ WYESHYALPL  
GRKKGAKLTP EEEEILNKKR SKKIQKKYDE 
RKKNAKISSL LEEQFQQGKL LACIASRPGQ  
CGRADGYVLE GKELEFYLRK IKARKGK 
74% 
16 RPL14 P50914 VFRRFVEVGR VAYVSFGPHA GKLVAIVDVI 
DQNRALVDGP CTQVRRQAMP FKCMQLTDFI  
LKFPHSAHQK YVRQAWQKAD INTKWAATRW 
AKKIEARERK AKMTDFDRFK VMKAKKMRNR  
IIKNEVKKLQ KAALLKASPK KAPGTKGTAA 
AAAAAAKVPA KKITAASKKA PAQKVPAQKA  
TGQKAAPAPK AQKGQKAPAQ KAPAPKASGK KA  
43% 
17 RPS2 P15880 MADDAGAAGG PGGPGGPGMG NRGGFRGGFG 
SGIRGRGRGR GRGRGRGRGA RGGKAEDKEW  
MPVTKLGRLV KDMKIKSLEE IYLFSLPIKE 
SEIIDFFLGA SLKDEVLKIM PVQKQTRAGQ  
RTRFKAFVAI GDYNGHVGLG VKCSKEVATA 
IRGAIILAKL SIVPVRRGYW GNKIGKPHTV  
PCKVTGRCGS VLVRLIPAPR GTGIVSAPVP 
KKLLMMAGID DCYTSARGCT ATLGNFAKAT  
FDAISKTYSY LTPDLWKETV FTKSPYQEFT 






Table 3.2 Sequence coverage of proteins using the bottom-up approach 
 
# Protein Accession #          Sequence Covered % 
18 RPL10 P27635 GRRPARCYRY CKNKPYPKSR FCRGVPDAKI 
RIFDLGRKKA KVDEFPLCGH MVSDEYEQLS  
SEALEAARIC ANKYMVKSCG KDGFHIRVRL 
HPFHVIRINK MLSCAGADRL QTGMRGAFGK  
PQGTVARVHI GQVIMSIRTK LQNKEHVIEA 
LRRAKFKFPG RQKIHISKKW GFTKFNADEF  
EDMVAEKRLI PDGCGVKYIP SRGPLDKWRA LHS 
81% 
19 RPL13a P40429 AEVQVLVLDG RGHLLGRLAA IVAKQVLLGR 
KVVVVRCEGI NISGNFYRNK LKYLAFLRKR  
MNTNPSRGPY HFRAPSRIFW RTVRGMLPHK 
TKRGQAALDR LKVFDGIPPP YDKKKRMVVP  
AALKVVRLKP TRKFAYLGRL AHEVGWKYQA 
VTATLEEKRK EKAKIHYRKK KQLMRLRKQA  
EKNVEKKIDK YTEVLKTHGL LV 
39% 
20 RPL9 P32969 MKTILSNQTV DIPENVDITL KGRTVIVKGP 
RGTLRRDFNH INVELSLLGK KKKRLRVDKW  
WGNRKELATV RTICSHVQNM IKGVTLGFRY 
KMRSVYAHFP INVVIQENGS LVEIRNFLGE  
KYIRRVRMRP GVACSVSQAQ KDELILEGND 
IELVSNSAAL IQQATTVKNK DIRKFLDGIY  
VSEKGTVQQA DE 
64% 
21 RPS5 P46782 MTEWETAAPA VAETPDIKLF GKWSTDDVQI 
NDISLQDYIA VKEKYAKYLP HSAGRYAAKR  
FRKAQCPIVE RLTNSMMMHG RNNGKKLMTV 
RIVKHAFEII HLLTGENPLQ VLVNAIINSG  
PREDSTRIGR AGTVRRQAVD VSPLRRVNQA 
IWLLCTGARE AAFRNIKTIA ECLADELINA  
AKGSSNSYAI KKKDELERVA KSNR 
70% 
22 RPS9 P46781 PVARSWVCRK TYVTPRRPFE KSRLDQELKL 
IGEYGLRNKR EVWRVKFTLA KIRKAARELL  
TLDEKDPRRL FEGNALLRRL VRIGVLDEGK 
MKLDYILGLK IEDFLERRLQ TQVFKLGLAK  
SIHHARVLIR QRHIRVRKQV VNIPSFIVRL 
DSQKHIDFSL RSPYGGGRPG RVKRKNAKKG  
QGGAGAGDDE EED 
87% 
23 RPL21 P46778 TNTKGKRRGT RYMFSRPFRK HGVVPLATYM 
RIYKKGDIVD IKGMGTVQKG MPHKCYHGKT  
GRVYNVTQHA VGIVVNKQVK GKILAKRINV 
RIEHIKHSKS RDSFLKRVKE NDQKKKEAKE  






P18621 VRYSLDPENP TKSCKSRGSN LRVHFKNTRE 
TAQAIKGMHI RKATKYLKDV TLQKQCVPFR  
RYNGGVGRCA QAKQWGWTQG RWPKKSAEFL 
LHMLKNAESN AELKGLDVDS LVIEHIQVNK  
APKMRRRTYR AHGRINPYMS SPCHIEMILT 






Table 3.2 Sequence coverage of proteins using the bottom-up approach 
 
# Protein Accession #          Sequence Covered % 
25 RPL11 P62913 AQDQGEKENP MRELRIRKLC LNICVGESGD 
RLTRAAKVLE QLTGQTPVFS KARYTVRSFG  
IRRNEKIAVH CTVRGAKAEE ILEKGLKVRE 
YELRKNNFSD TGNFGFGIQE HIDLGIKYDP  
SIGIYGLDFY VVLGRPGFSI ADKKRRTGCI 
GAKHRISKEE AMRWFQQKYD GIILPGK 
68% 
26 RPL12 P30050 MPPKFDPNEI KVVYLRCTGG EVGATSALAP 
KIGPLGLSPK KVGDDIAKAT GDWKGLRITV  
KLTIQNRQAQ IEVVPSASAL IIKALKEPPR 
DRKKQKNIKH SGNITFDEIV NIARQMRHRS  
LARELSGTIK EILGTAQSVG CNVDGRHPHD 
IIDDINSGAV ECPAS 
84% 
27 RPL26 P61254 MKFNPFVTSD RSKNRKRHFN APSHIRRKIM 
SSPLSKELRQ KYNVRSMPIR KDDEVQVVRG  
HYKGQQIGKV VQVYRKKYVI YIERVQREKA 
NGTTVHVGIH PSKVVITRLK LDKDRKKILE  
RKAKSRQVGK EKGKYKEETI EKMQE 
59% 
28 RPS11 P62280 MADIQTERAY QKQPTIFQNK KRVLLGETGK 
EKLPRYYKNI GLGFKTPKEA IEGTYIDKKC  
PFTGNVSIRG RILSGVVTKM KMQRTIVIRR 
DYLHYIRKYN RFEKRHKNMS VHLSPCFRDV  
QIGDIVTVGE CRPLSKTVRF NVLKVTKAAG 
TKKQFQKF 
76% 
29 RPS10 P46783 
 
MLMPKKNRIA IYELLFKEGV MVAKKDVHMP 
KHPELADKNV PNLHVMKAMQ SLKSRGYVKE  
QFAWRHFYWY LTNEGIQYLR DYLHLPPEIV 
PATLRRSRPE TGRPRPKGLE GERPARLTRG  
EADRDTYRRS AVPPGADKKA EAGAGSATEF 
QFRGGFGRGR GQPPQ 
47% 
30 RPS15 P62841 AEVEQKKKRT FRKFTYRGVD LDQLLDMSYE 
QLMQLYSARQ RRRLNRGLRR KQHSLLKRLR  
KAKKEAPPME KPEVVKTHLR DMIILPEMVG 
SMVGVYNGKT FNQVEIKPEM IGHYLGEFSI  
TYKPVKHGRP GIGATHSSRF IPLK 
64% 
31 RPS25 P62851 MPPKDDKKKK DAGKSAKKDK DPVNKSGGKA 
KKKKWSKGKV RDKLNNLVLF DKATYDKLCK  
EVPNYKLITP AVVSERLKIR GSLARAALQE 
LLSKGLIKLV SKHRAQVIYT RNTKGGDAPA  
AGEDA 
52% 
32 RPS17 P08708 GRVRTKTVKK AARVIIEKYY TRLGNDFHTN 
KRVCEEIAII PSKKLRNKIA GYVTHLMKRI  
QRGPVRGISI KLQEEERERR DNYVPEVSAL 
DQEIIEVDPD TKEMLKLLDF GSLSNLQVTQ  
PTVGMNFKTP RGPV 
85% 
33 RPS18 P62269 MSLVIPEKFQ HILRVLNTNI DGRRKIAFAI 
TAIKGVGRRY AHVVLRKADI DLTKRAGELT  
EDEVERVITI MQNPRQYKIP DWFLNRQKDV 
KDGKYSQVLA NGLDNKLRED LERLKKIRAH  





Table 3.2 Sequence coverage of proteins using the bottom-up approach 
# Protein Accession #          Sequence Covered % 
34 RPS13 P62277 GRMHAPGKGL SQSALPYRRS VPTWLKLTSD 
DVKEQIYKLA KKGLTPSQIG VILRDSHGVA  
QVRFVTGNKI LRILKSKGLA PDLPEDLYHL 
IKKAVAVRKH LERNRKDKDA KFRLILIESR  
IHRLARYYKT KRVLPPNWKY ESSTASALVA 
83% 
35 RPL27 P61353 GKFMKPGKVV LVLAGRYSGR KAVIVKNIDD 
GTSDRPYSHA LVAGIDRYPR KVTAAMGKKK  
IAKRSKIKSF VKVYNYNHLM PTRYSVDIPL 
DKTVVNKDVF RDPALKRKAR REAKVKFEER  
YKTGKNKWFF QKLRF 
67% 
36 RPL31 P62899 MAPAKKGGEK KKGRSAINEV VTREYTINIH 
KRIHGVGFKK RAPRALKEIR KFAMKEMGTP  
DVRIDTRLNK AVWAKGIRNV PYRIRVRLSR 
KRNEDEDSPN KLYTLVTYVP VTTFKNLQTV  
NVDEN 
66% 
 RPS14 P62263 APRKGKEKKE EQVISLGPQV AEGENVFGVC 
HIFASFNDTF VHVTDLSGKE TICRVTGGMK  
VKADRDESSP YAAMLAAQDV AQRCKELGIT 
ALHIKLRATG GNRTKTPGPG AQSALRALAR  
SGMKIGRIED VTPIPSDSTR RKGGRRGRRL 
46% 
37 RPS16 P62249 PSKGPLQSVQ VFGRKKTATA VAHCKRGNGL 
IKVNGRPLEM IEPRTLQYKL LEPVLLLGKE  
RFAGVDIRVR VKGGGHVAQI YAIRQSISKA 
LVAYYQKYVD EASKKEIKDI LIQYDRTLLV  
ADPRRCESKK FGGPGARARY QKSYR 
60% 
38 RPS20 P60866 MAFKDTGKTP VEPEVAIHRI RITLTSRNVK 
SLEKVCADLI RGAKEKNLKV KGPVRMPTKT  
LRITTRKTPC GEGSKTWDRF QMRIHKRLID 
LHSPSEIVKQ ITSISIEPGV EVEVTIADA 
88% 
39 RPS10 P46783 
 
MLMPKKNRIA IYELLFKEGV MVAKKDVHMP 
KHPELADKNV PNLHVMKAMQ SLKSRGYVKE  
QFAWRHFYWY LTNEGIQYLR DYLHLPPEIV 
PATLRRSRPE TGRPRPKGLE GERPARLTRG  
EADRDTYRRS AVPPGADKKA EAGAGSATEF 
QFRGGFGRGR GQPPQ 
40% 
40 RPL30 P62888 VAAKKTKKSL ESINSRLQLV MKSGKYVLGY 
KQTLKMIRQG KAKLVILANN CPALRKSEIE  
YYAMLAKTGV HHYSGNNIEL GTACGKYYRV 
CTLAIIDPGD SDIIRSMPEQ TGEK 
84% 
41 RPS19 P39019 PGVTVKDVNQ QEFVRALAAF LKKSGKLKVP 
EWVDTVKLAK HKELAPYDEN WFYTRAASTA  
RHLYLRGGAG VGSMTKIYGG RQRNGVMPSH 
FSRGSKSVAR RVLQALEGLK MVEKDQDGGR  
KLTPQGQRDL DRIAGQVAAA NKKH 
65% 
42 RPS15a P62244 VRMNVLADAL KSINNAEKRG KRQVLIRPCS 
KVIVRFLTVM MKHGYIGEFE IIDDHRAGKI  
VVNLTGRLNK CGVISPRFDV QLKDLEKWQN 









Table 3.2 Sequence coverage of proteins using the bottom-up approach.   
The red peptides were matched by peptide mass fingerprint.  The blue 
peptides were matched by performing microsequencing.  The sequence 
coverage is the number of amino acids covered by identifying peptides in the 
mass spectra divided by the number of amino acids in the protein.   
 
 
# Protein Accession #          Sequence Covered % 
43 RPS10 P46783 
 
MLMPKKNRIA IYELLFKEGV MVAKKDVHMP 
KHPELADKNV PNLHVMKAMQ SLKSRGYVKE  
QFAWRHFYWY LTNEGIQYLR DYLHLPPEIV 
PATLRRSRPE TGRPRPKGLE GERPARLTRG  
EADRDTYRRS AVPPGADKKA EAGAGSATEF 
QFRGGFGRGR GQPPQ 
32% 
44 RPL23 P62829 MSKRGRGGSS GAKFRISLGL PVGAVINCAD 
NTGAKNLYII SVKGIKGRLN RLPAAGVGDM  
VMATVKKGKP ELRKKVHPAV VIRQRKSYRR 
KDGVFLYFED NAGVIVNNKG EMKGSAITGP  
VAKECADLWP RIASNAGSIA 
46% 
45 RPL35a P18077 MSGRLWSKAI FAGYKRGLRN QREHTALLKI 
EGVYARDETE FYLGKRCAYV YKAKNNTVTP  
GGKPNKTRVI WGKVTRAHGN SGMVRAKFRS 
NLPAKAIGHR IRVMLYPSRI 
87% 
46 RPL38 P63173 PRKIEEIKDF LLTARRKDAK SVKIKKNKDN 
VKFKVRCSRY LYTLVITDKE KAEKLKQSLP  
PGLAVKELK 
68% 
47 RPS29 P62273 GHQQLYWSHP RKFGQGSRSC RVCSNRHGLI 
RKYGLNMCRQ CFRQYAKDIG FIKLD  
87% 
48 RPL37a P61513 AKRTKKVGIV GKYGTRYGAS LRKMVKKIEI 
SQHAKYTCSF CGKTKMKRRA VGIWHCGSCM  
KTVAGGAWTY NTTSAVTVKS AIRRLKELKD Q 
82% 
49 RPL22 P35268 APVKKLVVKG GKKKKQVLKF TLDCTHPVED 
GIMDAANFEQ FLQERIKVNG KAGNLGGGVV  
TIERSKSKIT VTSEVPFSKR YLKYLTKKYL 
KKNNLRDWLR VVANSKESYE LRYFQINQDE  
EEEEDED 
50% 
50 RPL36a P83881 VNVPKTRRTF CKKCGKHQPH KVTQYKKGKD 
SLYAQGKRRY DRKQSGYGGQ TKPIFRKKAK  
TTKKIVLRLE CVEPNCRSKR MLAIKRCKHF 
ELGGDKKRKG QVIQF 
49% 
51 RPL24 P83731 MKVELCSFSG YKIYPGHGRR YARTDGKVFQ 
FLNAKCESAF LSKRNPRQIN WTVLYRRKHK  
KGQSEEIQKK RTRRAVKFQR AITGASLADI 
MAKRNQKPEV RKAQREQAIR AAKEAKKAKQ  





In addition to database searching, the sequence coverage for each protein 
was determined by performing an in-silico digest, and finding the matching 
peaks in the spectra obtained from each spot.  Table 3.2 shows the sequence 
coverage obtained for each identified ribosomal protein.  The range of 
sequence coverage is from 32% to 92%.  The average and standard 
deviation of the percent sequence coverage is 66 ± 15% and the median is 
67.5%.   
 
Comparative Study Between Parental and MitoxantroneR MCF-7 Cells 
Gels were acquired from both the parental MCF-7 cell line and the MCF-7 cell 
line selected for resistance.  Figure 3.6 shows a zoomed picture of the 2D gel 
map from the parental cell line (left) and the mitoxantrone resistant cell line 
(right).  Comparative densitometry was performed using the Compugen 
program to compare the protein abundance profiles between three different 
pairs of gels from each of three harvests.  Three gels constituted each gel 
pair.  Figure 3.7 shows a representative Compugen image of the comparison 
of a registered image of three gels of ribosomal proteins extracted from one 
harvest of the parental cell line with a registered image of three gels of 
ribosomal proteins extracted from one harvest of the drug resistant cell line.  
The yellow circles indicate a decrease in protein abundance with respect to 
the parental cell line.  The red circles indicate the appearance of protein spots 























Figure 3.6 Zoomed views of the 2D gels of ribosomal proteins  
extracted from the parental cell line (left) and the mitoxantrone resistant 





























Figure 3.7 Compugen image of the comparison of the parental cell line 
and the mitoxantrone resistant cell line. 
 
The yellow circles represent a decrease in protein abundance in the 
mitoxantrone resistant cell line with respect to the parental cell line.  The red 
circles represent the appearance of proteins in the mitoxantrone resistant cell 



















Table 3.3 Relative quantitation of proteins with altered abundances 
The proteins with numbers for relative differences are present in both cell 
lines, and therefore a value can be obtained for differential abundance.  
Proteins that were only present in one cell line cannot be relatively quantified, 
since only one value is available. 
 
Spot # Protein Isoform Parental Cell Line MitoxantroneR Cell Line 
6 RPS3 1 0.43 ± 0.04 
7 RPS3 Not Present Present 
29 RPS10 1 0.27 
39 RPS10 Not Present Present 























Figure 3.8 RPS3 protein abundance changes 
The spot in the yellow circle decreases in the mitoxantrone resistant cell line 
(right panel) with respect to the parental cell line (left panel).  The spot in the 
red circle was also identified as RPS3, but is not present in the parental cell 























Figure 3.9 RPS10 protein abundance changes 
The spot in the yellow circle decreases in the mitoxantrone resistant cell line 
(right panel) with respect to the parental cell line (left panel).  The spots in the 
red circle was also identified as RPS10, but are not present in the parental 
cell line.   
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There are 5 differentially abundant spots detected in the mitoxantrone 
resistant cell line.  Table 3.3 shows the differentially abundant proteins as well 
as their relative quantitation as determined by the Compugen program.  
Figure 3.8 shows the abundance changes in ribosomal protein S3 (RPS3).  
The spot circled in yellow decreases in intensity in the gel from the 
mitoxantrone resistant cell line.  Conversely, the protein spot circled in red 
indicates the appearance of an isoform of RPS3 in the drug resistant cell line.  
The abundance changes in ribosomal protein S10 (RPS10) are shown in 
Figure 3.9.  Again, the protein yellow circle indicates a decrease in 
abundance in the mitoxantrone resistant gel.  The two red circles indicate the 
appearance of two isoforms of RPS10 in the drug resistant cell line.   
 
Characterization of Protein Isoforms 
A study was performed to test the extraction of the protein and 
determine the accuracy of the instrument.  A standard protein, apomyoglobin, 
was run on a gel and extracted using the described procedure.  The 
molecular weight of the protein was calculated to be 16952.27 Da, while the 
experimental molecular weight was 16953 Da as can be seen in Figure 3.10.  
This deviation in molecular weight represents a 0.004% error.     
A precision study was performed which tested the precision of the MALDI 
instrument.  In this study, two proteins were extracted from a gel and spotted 
























Figure 3.10 The intact molecular weight of the standard apomyoglobin 
The calculated MW for apomyoglobin is 16952.27 Da.  The observed 
molecular weight for apomyoglobin that was extracted from a 1D gel was 
























Trial # Mass Protein 1 (Da) Mass Protein 2 (Da) 
1 22215.3 21483.5 
2 22220.9 21484.8 
3 22202.1 21487.4 
4 22217.7 21484.4 
5 22215.7 21484.4 
6 22220.6 21478.0 
7 22217.6 21484.4 
8 22212.1 21482.4 
9 22225.1 21493.0 
10 22227.9 21484.4 








Table 3.4 Result of precision study of the MALDI-TOF 
Two proteins were extracted and spotted on the MALDI plate 10 times.  Ten 
measurements were made and recorded and the average and standard 
























Figure 3.11 Overlay of the spectra from the precision study 
The ten generated spectra were overlaid to obtain a visual description of the 




Spot # Protein Name Calc Mass Exp Mass Potential Mods ∆ Da 
3 RPL6 32634 32625  9 
4 RPL5 34352 34447 1P, 1O 95 
5 RPS3a 30023 30070 3O 47 
6 RPS3 26728 26761 2O 33 
7 RPS3 26785 26790  5 
8 RPS3 26671 25723  -948 
9 RPS4X 29619 29648 2O 29 
10 RPL13 24343 24929  586 
15 RPS8 24059 14298 C-term T 123-207 -9671
16 RPL14 23258 23260  2 
18 RPL10 24886 24897 1O 11 
20 RPL9 21964 22159  195 
21 RPS5 22902 22977 1Ac, 2O 75 
22 RPS9 22504 22500  4 
24 RPL17 (L23) 21480 21523 3O 43 
25 RPL11 20337 20384 2O, 1Me 47 
26 RPL12 17922 17924  2 
27 RPL26 17248 17291 2O, 1Me 43 
28 RPS11 18533 18533  0 
29 RPS10 18886 19020  134 
30 RPS15 16898 17016 7O 118 
31 RPS25 13791 13686 -Met,2Me -105 
32 RPS17 15466 15500 2O 44 
33 RPS18 17708 17624 -Met, 1O, 2Me -84 
34 RPS13 17081 17083  2 
35 RPL27 15657 15696 3Me 39 
36 RPS14 16302 16337 2O 35 
36 RPL31 14454 14183 -Met, -125 -271 
37 RPS16 16418 16425  7 
38 RPS20 13421 13422  1 
39 RPS10 18886 15102 C-term T -3784
40 RPL30 12816 12884 3O,1Me 68 
41 RPS19 16019 15958  -61 
42 RPS15a 14813 14874 3O, 1Me 61 
43 RPS10 18886 14931  -3955
44 RPL23 14913 14932 1O 20 
46 RPL38 8082 8154  -72 
47 RPS29 6541 7982  1441 
48 RPL37a 10137 10127  10 
   9599   
 
 
Table 3.5 Intact molecular weights of the ribosomal proteins 
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It was determined that the standard deviation of protein 1 was 7Da, while the 
standard deviation of protein 2 was 4 Da.  This shows that the instrument is 
capable of making precise measurements.   
Top-down and bottom-up proteomic approaches were combined in an 
attempt to elucidate the structural changes in the protein isoforms that appear 
in the drug resistant cell line.  The bottom-up approach involves protein 
digestion and subsequent mass spectrometry of peptides in an attempt to 
identify as many peptides as possible.  The results of these analyses can be 
seen in Table 3.2.  Molecular masses of peptides listed in red were matched 
to molecular masses of in-silico digestion.  The blue entries were matched 
using sequence tags.  Since not all peptides were found for the proteins, a top 
down approach was used to determine whether the protein appeared to be 
modified or unmodified.  In this case the intact molecular weight of a gel 
extracted protein was determined using MALDI analysis.  Table 3.5 shows the 
calculated and experimental molecular weights of ribosomal proteins, and a 
column which lists potential modifications, that could explain the observed 
mass differences.  The last column shows the difference between the 
calculated and experimental masses of each protein.    
 
Absolute Quantification of Ribosomes  
The number of ribosomes per cell was determined for both the parental 
and drug resistant MCF-7 cell lines.  This was achieved by counting the 
number of cells per harvest using a hematocytometer, then measuring the 
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number of ribosomes per harvest using a UV-Vis spectrophotometer.  The 
two numbers can be divided to give the number of ribosomes per cell.  Figure 
3.12 shows a bar graph which represents the number of ribosomes per cell 
for parental (red columns) and mitoxantrone resistant (blue columns) cell 
lines.  Figure 3.13 shows the bar graph representing the absorbances for the 
number of ribosomes per cell. Each column represents the average and 
standard deviation of eight measurements.    Figure 3.14 shows the bar graph 
representing the number of cells per harvest.  Each column represents the 
average and standard deviation of three cell counts.  No change was 









































Figure 3.12 Bar graph representation of the number of cell per harvest 
The number of cells per harvest was determined for three parental cell line 
harvests and three mitoxantrone resistant cell line harvests.  The average and 
standard deviation of two measurements per harvest is shown in the bar 





















Figure 3.13 Bar graph representation of the number of ribosome 
 per harvest 
 
The number of ribosomes per harvest was determined for three parental cell 
line harvests and three mitoxantrone resistant cell line harvests.  The average 
and standard deviation of eight measurements per harvest is shown in the bar 



























































Figure 3.14 Bar graph representation of the number of ribosomes 
 per cell 
 
The number of ribosomes per cell was calculated for three parental cell line 
harvests and three mitoxantrone resistant cell line harvests.  The average and 




Chapter 4: Discussion 
Characterization of the Ribosome 
 The ribosome is a cellular machine that synthesizes proteins.  Since 
the function of this macromolecule remains constant, it would be easy to 
conclude that the structure would also remain constant.  That is not the case, 
however, as it has been shown that structures of both the protein and rRNA 
content, which makes up the ribosome can differ under varying physiological 
conditions [20, 31, 34, 35, 98, 99].  Work has also been performed, which 
shows that the number of ribosomes in a cell can differ depending on various 
physiologic conditions [18, 100, 101].  Although the ribosome has been 
studied for 65 years, many of the details of its mechanism of protein synthesis 
are still undiscovered.  Specifically, functions have not been described for 
ribosomal proteins of any species.  Localizing the position of the proteins 
within the ribosome will aid in elucidation of their function, yet the crystal 
structures have only been reported for three organisms from archaea, and 
one bacterial.  About 30% of E. coli ribosomal proteins have orthologous 
counterparts in eukaryotic ribosomes, which share about 30% sequence 
homology.  The question remains whether assumptions can be made about 
eukaryotic ribosomes based on studies performed on bacterial or archaeic 
ribosomes.  
Considering that ribosomal proteins change as a result of a change in 
specific conditions, and that the specific function of ribosomal proteins are 
unknown, characterizing the proteins found in ribosomes may provide insight 
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into specific functions.  A method has been developed here, by which the 
ribosomal proteins of the MCF-7 drug susceptible and drug resistant cell lines 
were evaluated.  The proteins were separated by 2D gel electrophoresis, 
which had been optimized to separate basic proteins.  The proteins were 
identified using a “bottom-up” strategy.  The state of the modifications of the 
ribosomal proteins was evaluated using a combined “top-down bottom-up” 
strategy.   
 
Bottom-Up Characterization of the MCF-7 Ribosome 
Bottom-up characterization is used to identify proteins by analysis of the 
peptides produced by protease digestion.  The proteins can be identified by 
submitting a list of peptide masses to a database, by obtaining sequence tags 
using tandem mass spectrometry and submitting to a database or by 
submitting the tandem mass spectra to a search engine. In this study, protein 
spots were cut from 2D gels and peptides were generated by in-gel digestion.   
 
Optimization of 2D Gel Analysis 
The lack of reproducibility and poor resolution of proteins in the basic 
region of 2D gels has been widely reported [49-56].  Many factors contribute 
to the poor first dimension separation.  The first factor is the migration of the 
reducing agent dithiothreitol towards the anode of the focusing chamber 
during isoelectric focusing. The results of this migration are the formation of 
intra- and inter- molecular disulphide bridges in the unprotected protein.  This 
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produces proteins in various states of oxidation and therefore multiple 
populations of a single protein are visible on the gel.  A second factor 
resulting in poor resolution of basic proteins by 2D gel electrophoresis is the 
amount of protein loaded onto the first dimension strip.  Experiments have 
shown that loading a smaller protein amount leads to increased resolution in 
the basic region of the gel [54, 55].  These limitations were overcome by 
using a DTT saturated wick at the cathode end of the focusing tray and 
decreasing the amount of protein loaded onto the gel. 
It was reported that using longer immobilized pH gradient strips or 
large format gels decreased the quality of the gel because longer strips 
increase the amount of horizontal streaking observed in the gel [55].  Once 
the optimization steps discussed above were applied to the electrophoresis, a 
large format gel could be used without the excessive horizontal streaking that 
was previously described.  The effect was better resolution of the protein 
spots and more space between each of the protein spots.  The final result 
was that ribosomal proteins were able to be separated and well-resolved by 
2D gel electrophoresis, which can be seen in Figure 3.4.    
 
Identification of Proteins 
Due to an apparent heterogeneity of the human ribosome, a definitive 
number of proteins expected in the ribosome has not been determined to date 
[4, 20, 21, 98]. The number of proteins in the E. coli ribosome was determined 
in 1970 by Kaltschmidt and Wittman using 2D gel electrophoresis [14].  The 
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same method was applied to ribosomes harvested from rat liver in 1972, and 
69 proteins were found [13].  Early reports of the number of ribosomal 
proteins in HeLa cells reported 34 proteins in the large ribosomal subunit and 
17-20 proteins that always occurred in the small subunit [21].  In addition, 
there were 10 proteins that were sometimes found in the ribosomal fraction. It 
has since been determined that all mammalian ribosomes consist of about 
78-80 ribosomal proteins per ribosome [4].  Recent reports which evaluate 
either the small subunit [41] or the large subunit [36] have found 31 and 46 
ribosomal proteins respectively.    
The SwissProt database contains 84 ribosomal protein entries, which 
are listed in Table 4.1.  Using a theoretical isoelectric point calculator, [102] it 
was determined that 45 of these ribosomal proteins are in the pI range 7-11.  
This is significant because it was the pI range of the first dimension gel used 
in this work.  Forty-nine ribosomal proteins were identified, and are red in 
color in Table 4.1.  Thirty-six were calculated to be in the pI range of 7-11.  
Thirteen ribosomal proteins were identified, whose calculated pI’s were 
determined to be higher than 11.  Nine ribosomal proteins, whose calculated 
pI’s are in the range, were not identified and are blue in color in Table 4.1.   
Structural redundancy, in which more than one ribosomal protein has a 
very similar sequence to another, is a common theme observed in human 
ribosomal proteins.  For example, ribosomal protein S4 has three isoforms; 
S4X, S4Y1, and S4Y2.  Since these proteins share such high homology, it 
would be reasonable to assume that they would perform similar functions.  As 
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a result, only one of the three protein isoforms might be observed in the 
ribosomes.  Four of the proteins that were expected, but not identified, had a 
high level of sequence homology with proteins that were identified.   
Another possible reason for not observing all of the proteins that were 
expected in this region is the method for isolation of the ribosomal proteins.  
The classic method of ribosomal isolation is using acetic acid to remove the 
ribosomal RNA followed by acetone to precipitate the proteins [94].  Suh et al. 
investigated other methods and reagents to obtain ribosomal proteins prior to 
mass spectrometry [42].  They concluded that even with many optimization 
steps, only 90% of the expected ribosomal proteins could be observed in the 
mass spectrum.  In addition, they found that the low molecular weight 
ribosomal proteins were more sensitive to sample preparation and therefore 
less likely to be seen in the spectrum.  These results are consistent with what 
was observed in this work.  Four of the proteins that were expected, but not 
identified had molecular weights below 10kDa.  A theoretical digest was 
performed using the PeptideCutter program to compare the number of 
peptides generated from the small ribosomal proteins using three different 
proteases.  The results are shown in Table 4.2. 
The results show that a similar number of peptides are generated in 
the detectable range of 600-3000 Da whether trypsin or lys-c are used as a 






Table 4.1 The list of human ribosomal proteins in the SwissProt  
database 
Protein Name MW PI Accession Number 
RPL3 45949 10.62 P39023 
RPL4 47697 11.5 P36578 
RPL5 34295 10.05 P46777 
RPL6 32577 11.03 Q02878 
RPL7 29207 11.07 P18124 
RPL7A 29846 11.06 P62424 
RPL8 27876 11.45 P62917 
RPL9 21850 10.37 P32969 
RPL10 24430 10.49 P27635 
RPL10A 24684 10.36 P62906 
RPL11 20109 9.96 P62913 
RPL12 17808 9.9 P30050 
RPL13 24130 12.06 P26373 
RPL13A 23446 11.36 P40429 
RPL14 23158 11.41 P50914 
RPL15 24015 12.02 P61313 
RPL17 21266 10.6 P18621 
RPL18 21503 12.13 Q07020 
RPL18A 20762 11.15 Q02543 
RPL19 23466 11.89 P84098 
RPL21 18434 10.91 P46778 
RPL22 14656 9.61 P35268 
RPL23 14865 10.94 P62829 
RPL23A 17695 10.89 P62750 
RPL24 17779 11.69 P83731 
RPL26 17248 10.98 P61254 
RPL26-l 17246 10.98 Q9UNX3 
RPL27 15657 10.98 P61353 
RPL27A 16430 11.42 P46776 
RPL28 15616 12.42 P46779 
RPL29 17621 12.08 P47914 
RPL30 12645 9.96 P62888 
RPL31 14454 10.97 P62899 
RPL32 15729 11.74 P62910 
RPL34 13162 11.88 P49207 
RPL35 14420 11.48 P42766 
RPL35A 12530 11.46 P18077 
RPL36 12123 12 Q9Y3U8 
RPL36A 12302 11.03 P83881 
RPL36A-l 12338 11.1 Q969Q0 
RPL37 10947 12.15 P61927 
RPL37A 10137 10.44 P61513 
RPL38 8085 10.56 P63173 
RPL39 6275 12.96 P62891 
RPL39-l 6161 12.81 Q96EH5 
RPL40 6181 10.73 P62987 
RPL41 3456 13.36 P62945 
RPSA 32723 4.95 P08865 
RPS2 31305 10.65 P15880 
RPS3 26671 10.04 P23396 
RPS3A 29795 10.04 P61247 
RPS4X 29448 10.59 P62701 
RPS4Y 29324 10.68 P22090 
RPS4Y2 29164 10.51 Q8TD47 
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RPS5 22731 10.09 P46782 
RPS6 28663 11.29 P62753 
RPS7 22127 10.58 P62081 
RPS8 24059 10.72 P62241 
RPS9 22447 11.09 P46781 
RPS10 18886 10.51 P46783 
RPS11 18419 10.71 P62280 
RPS12 14395 6.34 P25398 
RPS13 17081 10.94 P62277 
RPS14 16131 10.53 P62263 
RPS15 16898 10.79 P62841 
RPS15A 14699 10.61 P62244 
RPS16 16304 10.57 P62249 
RPS17 15409 10.24 P08708 
RPS18 17708 11.42 P62269 
RPS19 16109 10.73 P39019 
RPS20 13364 10.44 P60866 
RPS21 9111 8.89 P63220 
RPS23 15676 10.96 P62266 
RPS24 15423 11.24 P62847 
RPS25 13734 10.58 P62851 
RPS26 12884 11.42 P62854 
RPS27 9330 9.84 P42677 
RPS27A 9418 10.22 P62979 
RPS28 7841 11.15 P62857 
RPS29 6541 10.17 P62273 
RPS30 6648 12.56 P62861 
RPP0 34274 5.6 P05388 
RPP1 11514 4 P05386 










Table 4.1 The list of human ribosomal proteins in the SwissProt 
database. 
 
The proteins highlighted in red were identified in this study.  The proteins 
highlighted in blue were in the pI range evaluated in this study, but were not 




























Figure 4.1 A ClustLW sequence alignment of three isoforms of 
ribosomal protein S4.  
 










The usual goal of bottom-up analysis of proteins is to identify the protein.  
This requires a minimum of two sequence tags or five peptide mass matches 
[73].  Tryptic peptides of basic ribosomal proteins are particularly small due to 
the frequent occurrence of lysine and arginine residues.  Two sequence tags 
or five peptides would not represent or cover a very large portion of the 
sequence of the protein.   
Ribosomal proteins are known to contain many post-translational 
modifications (PTM’s). Many recent papers that identify the proteins also 
make an attempt to identify the PTM’s [36-39, 41, 42, 84, 85].  Identifying a 
few out of many possible peptides would not likely lead to identification of the 
PTM’s.  For that reason, analyses were performed in ways designed to 
maximize the number of peptides identified for each protein.  One report in 
the literature cites 14-70% sequence coverage for ribosomal proteins, with 
more than half of the proteins having over 41% sequence coverage [35]. 
For 37 of the proteins studied here, at least 60 % of the sequence was 
covered in the spectra of the peptides of those proteins.  The general trend is 
that for proteins with less intense spots on the gel, less of the sequence was 
characterized.  For intense spots on the gel, better sequence coverage was 
obtained.  The identification of PTM’s can be supported by database 
searching.  When submitting tandem MS data in our study, the following 
































Table 4.2 In-silico digest of small molecular weight ribosomal proteins 
in the detectable range 
 
The detectable range is 600Da to 3000Da.  Although Lys-C only cuts at lysine 
residues, it makes about the same amount of peptides as trypsin.  Glu-C 
make fewer peptides, which are larger in size.   
Number of Peptides in Mass Range of Detection  
Trypsin Lys-C Glu-C 
RPS21 7 8 5 
RPS27 11 11 3 
RPS27a 7 6 5 




the search:  acetylation, methylation, and phosphorylation.  These 
modifications are the most common modifications reported on ribosomal 
proteins. 
 
Top-Down Characterization of the MCF-7 Ribosome 
The goal of the proteomic top-down approach is to experimentally 
obtain an intact molecular weight for a protein, followed by gas phase 
fragmentation and sequencing of the protein. Two common methods are 
applied in this way.  The first is a one or two dimensional gel electrophoresis 
experiment. Molecular mass is estimated by movement of the protein, and a 
limitation of this method is the error, up to 10%, in the determination of 
molecular weights. Proteins are identified following excision from the gel and 
trypsin digestion. 
  In the second method the molecular weight of the intact protein is 
obtained using mass spectrometry.  This measurement has a 0.05-0.1% error 
for proteins under 30kDa.  In the latter approach, after determination of the 
intact molecular weight, the protein is fragmented in the gas phase [75, 81, 
83, 103].  As in bottom-up analysis, 100% sequence coverage of the protein 
is desired.  An additional objective of this method is to induce cleavages at 
every peptide bond.  This allows very specific localization of post-translational 
modifications.  In practice, 137 of the possible 258 amide bonds were cleaved 
for carbonic anhydrase [75] in one study, while 250 of the possible 258 amide 
bonds were cleaved for carbonic anhydrase in a later study [77].  
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In addition, the reports of high levels of cleavage usually involve the 
use of high amounts of purified protein standards.  The application of these 
techniques to mixtures of harvested proteins has not proven to be nearly as 
successful.  The most useful piece of information gathered from top-down 
experiments with “wild-type” proteins is the intact molecular weight.  
Determining the experimental molecular weight for a protein is a way of 
scanning whether the protein is modified or unmodified.  In addition, if the 
experimental molecular weight does not agree with the theoretical molecular 
weight, the amount of deviation will narrow down the potential post-
translational modifications.  For instance, if the deviation from the theoretical 
molecular weight is 44 Da, phosphorylation (addition of 80 Da) is not the 
modification.  Researchers have employed this approach to narrow down the 
proteins which required further characterization of post-translational 
modifications [104, 105].   
In this work, intact molecular weights were determined for 41 ribosomal 
proteins.  The proteins were already identified by bottom-up analysis by in-gel 
digestion.  Since the protein spots had been identified, the calculated 
molecular weight for each protein could be determined.  The intact proteins 
were extracted from the gel spots and their molecular weights were 
determined using MALDI. 





Optimization of Extraction of Ribosomal Proteins from Gels  
Since the ribosomal proteins had already been identified in the gel, a 
method was desired in which the intact protein could be extracted from the 
gel for analysis. This tactic simplifies the correlation between the protein’s 
identification and its molecular weight.  Multiple approaches exist in the 
literature.  In one approach, MALDI analysis was performed on the protein 
that was still in the gel [106-109].  The gels were usually soaked in MALDI 
matrix, and mounted onto the MALDI plate.  In a second approach, the 
proteins were blotted from the gel to a membrane such as PVDF or 
nitrocellulose.  MALDI analysis can then be performed directly from the 
membrane [110-112], or the protein can be extracted from the membrane and 
analysed [113, 114].  The third approach involves the direct extraction of the 
protein from the gel into solution.  Two methods have been employed:  
electroelution, or chemical elution.  The commercial electrelutor applies a 
voltage creating an electric field which elutes the protein from the gel and 
dialyses it into the buffer of choice [115].  In passive elution, the gel piece 
containing the protein is soaked in an extraction solution to recover the 
protein [96, 107, 113, 116-119].  It is noteworthy that all of the solution 
extraction analyses were performed using proteins recovered from one 
dimensional gels.   
The first approach, performing mass spectrometric analysis directly on 
the gel, was not attempted.  Since the analyzer on our MALDI instrument is 
time-of-flight, distance from the point of ionization to the detector determines 
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the mass accuracy of the measurement. It has been determined that when 
the thickness of a MALDI matrix spot differs, mass accuracy and resolution 
will vary as well [120].  It was therefore decided that the thickness of the gel 
would invite variations that could be avoided.   
The second approach of electroblotting the proteins to a membrane 
was attempted.  Using the method based on Towbin [121], the gel was 
electroblotted onto PVDF membranes. An attempt was made to remove the 
protein from the membrane for subsequent mass spectrometric analysis.  The 
piece of PVDF membrane with the protein spot was placed in an extraction 
solution.  The blotting itself was efficient as determined by using colorimetric 
standards.  The extraction from the membrane was evaluated by the 
disappearance of the color from the membrane.  This approach did not 
provide a good mass spectrum.    
The third approach proved to be the most successful. Although 
solution extraction methods from multiple groups were evaluated, the method 
Mirza et al. was the only one that provided results with our proteins [96].  This 
method has a fairly extensive destaining process, followed by a simple 
extraction using 50%ACN/0.1% TFA, which is the solvent for MALDI matrix.  
The method effectively destained and extracted the proteins from the gel 
pieces and allowed for MALDI analyses of intact molecular weights from the 





MALDI optimization for molecular mass determination 
Mass spectrometry was optimized by adjusting the solubilizing 
solutions.  It was determined that using a 50% ACN with 1%TFA for 
solubilizing the matrix resulted in a much improved MS signal intensity.   In 
addition, mixing Triton X-100 with the extracted sample to a final 
concentration of 2.5% resulted in increased MS signals as well as increases 
in resolution.  There was a very noticeable decrease in the width of the peak 
as well as a decrease in the adduct peaks observed.  The addition of Triton 
X-100 produced a doubly-charged protein peak in many instances.   
 
Intact Molecular Weights 
Obtaining intact molecular weights for ribosomal proteins provides 
insight into the level of post-translational modification of the proteins.  This 
approach has been taken to analyze E. coli proteins [37, 42, 84, 85] and 
proteins from the microbe Rhodopseudomonas palustris, which is 
environmentally important and has a completely sequenced genome [38].  
Post-translational modifications such as loss of N-terminal methionine, 
methlyation, and acetylation, loss of signal peptide, B-methylthiolation, and C-
terminal truncation were all hypothesized as modifications which lead to the 
differences between experimental masses and calculated masses in these 
prokaryotic proteins.   
Fewer reports exist on the intact molecular weight determination of 
eukaryotic ribosomal proteins.  The yeast large subunit ribosomal proteins 
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were analyzed by LC-MS and intact molecular weight determination revealed 
PTM’s such as acetylation and methylation [39].  In addition, 58 protein 
isoforms were identified, 9 masses were not correlated with a protein, and 6 
proteins were not associated with a mass.  This is a strong indication of 
various forms of truncation or a large amount of processing, which could not 
be resolved.    
The small ribosomal subunit of the rat ribosome was analyzed using an 
LC-MS based system [34].  In this case, 41 total proteins were observed.  
Thirty-six proteins were correlated to the 32 rat liver small ribosomal subunit 
proteins. Four proteins were observed to have two isoforms.  Twelve proteins 
exhibited masses that were consistent with the calculated mass; 15 differed 
by mass increments readily assignable to PTM, while seven showed masses 
that were inconsistent with known modifications.  Five masses could not be 
correlated with any protein in the database.  In this case, multiple isoforms of 
some ribosomal proteins could be resolved.   
  Proteins from the small subunit of human ribosomes have been  
analyzed using N-terminal sequencing and mass spectrometry [40] and top-
down bottom-up analysis [41].  In the former study, 32 ribosomal proteins 
from human placenta were separated by offline HPLC and analyzed. Two 
proteins were found to have different N-terminal sequences than what was 
present in the database. One protein, RPS24, was found to have a 318 Da 
mass difference between calculated and observed molecular weights.   
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In the latter study, 31 ribosomal proteins were identified using the top-
down, bottom-up approach.  N-terminal methionine loss, acetylation and 
methylation were detected.  Two proteins were found to be differentially 
modified between the healthy and ribosomes from Hepatitis C infected cell 
small subunits, RP25 and RP29. Of the 22 proteins identified using the top-
down approach, all of them contained post-translational modifications.  Thirty-
one proteins were identified using the bottom-up approach, and all but one 
was modified.  Many of the peptides containing the modifications were not 
discovered.   
These and other literature reports demonstrate the variability of 
ribosomes found in all types of organisms.  They have shown that the number 
of detected ribosomal proteins varies, the masses vary, the isoforms vary, 
and the sequences vary.  In one 2D gel based bottom-up study performed on 
Arabidopsis thaliana, 25% of the proteins has mass or charge differences 
[35]. More than 18 ribosomal proteins were identified in more than one spot 
on the gel, meaning that multiple populations existed for those 18 proteins.  
This observation indicates biochemical variation.  Depending on the method 
of detection, data obtained from the proteins is often not correlated with 
proteins because of the degree of variation. The results obtained in this study 
are consistent with those that are published as can be seen in Table 3.5.  
Some of the ribosomal proteins have molecular weights that are so different 
than the calculated molecular weight the modifications cannot be deduced or 
hypothesized.     
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Implications for Methods to Multidrug Resistance in Breast Cancer 
Multi-drug resistance is the most common cause of cancer treatment 
failure.   The cytotoxicity of most chemotherapy drugs initiates apoptosis in 
non-resistant cells [122].  A defect in the apoptotic pathway can lead to 
tumorigenesis and progression of the disease that results from the mutation.  
In addition tumors must circumvent cellular responses such as hypoxia, 
nutrient deprivation, changes in adhesion, and immune attacks to progress 
and metastasize [123].  Each of these obstacles acts as a selective pressure 
to alter the apoptotic pathway or promote other mechanisms of resistance.   
The amount of ribosomes in a cell is a factor that has been reported to 
change based on various cellular changes. One such study reports an 
increase in the number of ribosomes as a result of an increase in calcium 
influx [18].  Another study reports that an increase in the number of ribosomes 
was observed when a DNA inverting enzyme, which stimulates the production 
of rRNA, was overexpressed [100].   
The number of cells in a harvest was counted using a 
hematocytometer.  Ribosomes were quantitated after isolation by taking the 
absorbance reading at 260nm.  One Absorbance unit at 260nm is equal to 19 
pmol of ribosomes [97].  Using this conversion, the number of ribosomes in a 
harvest could be calculated.   The procedure was performed for both the 
parental MCF-7 as well as the mitoxantrone resistance MCF-7 cells.  It was 
determined that the number of ribosomes per cell was not statistically 
different between the cell lines.   
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Ribosomal proteins are known to be involved in apoptosis and, thus 
potentially, multidrug resistance.  Ribosomal protein S3, which was found to 
be modified in the present work, and ribosomal proteins S13 and L23 
reportedly promote multidrug resistance by suppressing drug induced 
apoptosis [124-126].   
Alternative isoforms of RPS3 and RPS10 appeared in the gel of the 
drug resistant cell line, which can be seen circled in red in Figures 3.8 and 
3.9.  Although functional studies have not yet been performed for most 
eukaryotic ribosomal proteins, the literature reports of these proteins provide 
insight into their functions in varying experimental conditions.  In addition, 
literature reports indicate altered structures for these ribosomal proteins in 
other circumstances.   
 
RPS3 
In the drug resistant cell line, the RPS3 spot found in the parental cell 
line decreased in abundance, while another RPS3 isoform appeared.  The 
novel isoform had a molecular mass that was 948 daltons less than the 
calculated molecular weight.  The literature indicates that modifications of 
RPS3 are variable and that the type of modifications cannot be directly 
discerned because of the large molecular weight changes.  As evaluated by 
migration in a 2D gel, Chang et.al. determined a mass shift in RPS3 [35].  The 
intact molecular weight of RPS3 was not determined using the top-down 
approach by Yu et al, because a molecular weight corresponding to that 
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protein  was not found [41].  A mass difference of (+) 228 Da was reported in 
a human ribosomal protein by Vladimirov et.al. [40].  In a rat protein, a mass 
difference of (-) 362.1 Da was observed in one isoform of RPS3 [34].  The 
second identified isoform of RPS3 had a mass difference of (-) 74.9 Da as 
determined by Louie et.al. [34].  It is clear that RPS3 is commonly reported as 
modified and that the nature of the modification varies.    
 
RPS10 
Two additional isoforms of RPS10 appeared in the drug resistant cell 
line.  The spot identified as RPS10 in the drug susceptible cell line was 
decreased in abundance in the drug resistant cell line relative to the drug 
susceptible cell line.  The molecular masses of the two novel isoforms were 
14931 Da and 15102 Da.  This represents a decrease from the expected 
molecular weight of 3784 Da and 3955 Da respectively.  Chang et. al. 
observed a mass shift in ribosomal protein S10 based on its migration in a 2D 
gel [35].  Using mass spectrometry, an increase in mass corresponding to the 
addition of a methyl group and an acetyl group were observed by Yu et al 
[41].  In the work performed by Vladimirov et al. ribosomal protein S10 was 
not determined because at the time of publication, the sequence of RPS10 
was unknown [40].   In the work performed by Louie et al., RPS10 was 
determined to have a mass change of (+) 57 Da [34].  Again it is apparent that 
the changes in RPS10 can be difficult to characterize.   
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The changes in the ribosome observed in this study need to be 
considered in the context of changes in other parts of the cell.  The cell is a 
functioning unit therefore the changes that take place as a result of multidrug 
resistance will be global.  In addition, drug resistance in cancer is 
multifactorial, meaning that differing mechanisms of resistance are 
simultaneously working to create a state of drug resistance in the cell.  No 





The conclusion can be made that changes in abundance of ribosomal 
protein isoforms in the MCF-7 cell line are associated with resistance to 
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